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1  INTRODUCTION 
 
Over the last years the pig as model organism for biomedical research becomes more 
and more attractive due to similarities in anatomy, size, life span, physiology, 
metabolism and pathology with humans (reviewed in Aigner et al. 2010). The 
relatively fast maturation rate and large number of offspring in pigs can be considered 
appropriate and make them more suitable for research than other larger animals like 
cow, sheep or dog (reviewed in Lunney 2007). Furthermore, the requirements for 
organs for transplantation in human may be satisfied by pigs as organ donors 
(reviewed in Klymiuk et al. 2010). 
The generation of transgenic pigs is achievable in different ways, including 
pronuclear microinjection of DNA, sperm-mediated gene transfer, retroviral 
transduction and genetic manipulation of cells in culture followed by somatic cell 
nuclear transfer (SCNT) (reviewed in Wolf et al. 2000 and Robl et al. 2007). Due to a 
lack of definitive embryonic stem cells in pig (reviewed in Vackova et al. 2007), 
SCNT is the method of choice for genetic engineering of pigs, especially for gene 
targeting. Depending on the question that is addressed to the transgenic pig model, 
donor cells are modified via additive gene transfer, where the modification is 
achieved by random integration of an expression vector into donor genome or by site-
directed modification of a target locus via homologous recombination (Thomas et al. 
1986).  
The outcome of pig cloning is influenced by several parameters, such as oocyte 
quality and preparation, properties of donor cells, nuclear transfer protocol, embryo 
culture and recipient animal (Polejaeva et al. 2000; reviewed in Campbell et al. 
2005). Not all parameters can be influenced properly, but donor cells with appropriate 
characteristics can be chosen. These are long lifespan, exhibition of a stable 
karyotype even after a long culture period, suitability for genetic modification, 
capability for in vitro and in vivo development after transfer into an enucleated oocyte 
and embryo transfer.  
Up to now several different somatic porcine cells were used for SCNT, such as 
multipotent stem cells (Colleoni et al. 2005; Jin et al. 2007), fetal cells (Onishi et al. 
2000; Kumar et al. 2007) and adult cells (Polejaeva et al. 2000; Petersen et al. 2008).  
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The genetic modification of donor cells for SCNT requires efficient transfer of DNA 
into cells and integration into the genome. There are different ways to transfect 
primary mammalian cells, for instance with chemical methods like calcium phosphate 
method (Graham and van der Eb 1973), lipofection (Felgner et al. 1987), nanofection 
(Orth et al. 2008) and with physical methods like microinjection (Liu et al. 1979), 
electroporation (Andreason and Evans 1988), nucleofection (Nakayama et al. 2007) 
as well as viral transduction (Follenzi et al. 2000). Since properties of primary cell 
types are very different, each cell type has to be characterized regarding to lifespan, 
stability of karyotype, proliferation capacity, transfectability and in vitro development 
competence of embryos after SCNT. 
The aim of this thesis was the evaluation of primary cell cultures isolated from 
different tissues regarding their suitability for generation of transgenic pigs by SCNT. 
To follow this aim, several important characteristics of cultured porcine kidney cells 
(PKCs), fetal fibroblasts (PFFs) and ear fibroblasts (PEFs) had to be determined. 
i) Morphology and growth potential 
The cells were analyzed morphologically after isolation, during culture as 
well as after long periods in culture. The proliferation capacity was studied 
by creation of a growth curve and the growth properties of cells were 
analyzed by MTT assay using different coating types. In addition, stable 
metaphases were examined even after a long culture period. Moreover, the 
in vitro development competence of embryos after SCNT using the several 
donor cells were determined as well as the blastocyst rate/quality and 
nuclei number of obtained embryos after seven days. 
ii) Determination of appropriate transfection method 
The comparison of different transfection methods (lipofection, 
nanofection, conventional electroporation and nucleofection) was 
performed using PKCs in which transfection efficiency, fluorescence 
intensity, quality of cells and amount of dead cells, after transient 
transfection with a GFP expressing plasmid were determined. 
iii) Comparison of SCNT experiments 
Over the past four years a large number of transgenic animals was 
generated by SCNT at the Chair for Molecular Animals Breeding and 
Biotechnology. These results were compared regarding to the used donor 
cells and the obtained litter after embryo transfer (ET) experiments. 
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2  REVIEW OF THE LITERATURE 
 
 
2.1  Pig models for biomedical research 
 
Animal models are used for research of human diseases. For the selection of an 
animal model following points are important: aim of research, availability, costs, ease 
of handling as well as anatomical and physiological analogies to human. The most 
widely used animals in research, especially in biomedical research, are still rodents. 
The advantages of rodent models are low maintenance costs, high reproduction rate 
and well defined genetic background. In the case of mice there are a lot of transgenic 
and knockout animals available (reviewed in Aigner et al. 2010). 
One disadvantage of the mouse model is the relatively short lifespan. Larger animal 
models allow extended observation periods, which are important for different 
diseases including cancer, diabetes or neurodegenerative diseases. Furthermore, 
larger animals are more suitable than mice for surgery, blood sampling, serial 
biopsies, whole-organ manipulation and a lot of different biomedical applications 
(Reynolds et al. 2009; Roberts et al. 2009). 
Especially pigs have gained importance for translational biomedical research in recent 
years, because of their physiological and anatomical similarities with humans. They 
are closer with humans in size, life span, biochemistry and genetics than rodents or 
other domestic animals (reviewed in Aigner et al. 2010). The relatively fast 
maturation rate and the large number of offspring in the pig are beneficial and make 
them more suitable for research than other larger animals like cow, sheep or dog 
(reviewed in Lunney 2007 and Rogers et al. 2008a). Furthermore, pigs are 
omnivorous and their gastrointestinal morphology, digestive effectiveness and the 
energy metabolism are close to humans (reviewed in Miller and Ullrey 1987 and 
Aigner et al. 2010), so they are suitable for the investigation of obesity in human, 
metabolic syndrome and human nutrition (Spurlock and Gabler 2008). A great 
advantage of the pig as a biomedical model is the high DNA sequence homology and 
chromosome structure with humans (Wernersson et al. 2005; reviewed in Lunney 
2007).  
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In addition to the general suitability of pig models for biomedical research, transgenic 
pigs provide great potential for human disease studies, e.g. for cystic fibrosis (CF) 
(Rogers et al. 2008b; Klymiuk et al. 2011a), diabetes (Umeyama et al. 2009; Renner 
et al. 2010), xenotransplantation (Lai et al. 2002; Hauschild et al. 2011), vaccine 
development for infectious agents (Mendicino et al. 2011), Alzheimer´s disease 
(Kragh et al. 2009), breast cancer (Luo et al. 2011), cardiovascular disease (Hao et al. 
2006) and atherosclerosis (Wei et al. 2012). 
Transgenic mouse models often do not faithfully mimic the human phenotype, as 
seen in the gene-targeted mouse for cystic fibrosis (CF), which did not show the 
characteristic human pathology like abnormalities of lung, liver and other organs 
(reviewed in Grubb and Boucher 1999). In contrast, transgenic pig models show often 
similar disease progression as human patients (reviewed in Lunney 2007). Therefore, 
Rogers et al. (2008b) generated pigs either with a knock-out (CFTR
+/-
) of the cystic 
fibrosis transmembrane conductance regulator (CFTR) gene or a knock-in 
(CFTR
ΔF508
). They also generated CFTR
-/-
 pigs by breeding of the heterogeneous 
CFTR knock-out animals. The CFTR
-/-
-targeted new born pigs showed several disease 
characteristics like new born humans with CF. These similarities of disease 
characteristics were further demonstrated by CFTR
-/-
 pig model, which were 
generated by BAC-technology and homologous recombination (HR) (Klymiuk et al. 
2011a). 
Xenotransplantation is another important application of transgenic pigs; therefore 
organs are transplanted from other species into human, because the number of human 
organ donors is very limited. Normally, organ transplantation from pig to human 
results in hyperacute rejection which is a rapid and massive immune response against 
the key xenoantigen on pig cells galactosyl alpha(1-3) galactose (Platt et al. 1991; 
Cozzi et al. 2000). Thereby, the enzyme alpha-1,3-galactosyltransferase (GGTA1) 
plays a key role and Lai et al. (2002) generated the first GGTA1 knock-out pig. In 
addition to the knock-out of the GGTA1 gene, also tissue-specific expression of 
human complement regulatory proteins and other genetic factors are important for 
transplantation of pig tissue into humans (reviewed in Klymiuk et al. 2010). 
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2.2  Genetic engineering of pigs 
 
The generation of transgenic pigs can be achieved in different ways. Random 
integration of a transgene can be obtained by pronuclear microinjection of DNA, 
sperm-mediated gene transfer (SMGT), viral transgenesis as well as somatic cell 
nuclear transfer (SCNT) using genetically modified donor cells. In addition, SCNT is 
suitable for generation of pigs containing a site-directed genomic modification after 
gene targeting in the donor cell (Fig. 1).  
 
 
 
Figure 1: Different methods to generate transgenic pigs. 
(1) DNA transfer via pronuclear microinjection; (2a) sperm mediated gene transfer (SMGT) and (2b) 
intracytoplasmic sperm injection (ICSI); (3) retroviral transgenesis can be applied by subzonal 
injection of viral particles into oocytes and zygotes, respectively; (4) somatic cell nuclear transfer 
(SCNT) of a genetically modified donor cell into enucleated oocyte. (adapted from Aigner et al. 
(2010)) 
 
2.2.1  Pronuclear DNA microinjection 
 
Pronuclear DNA microinjection was the most widely used method to produce 
transgenic pigs for many years. The method has been used first successfully in mice 
and five years later the first transgenic pig was born after pronuclear microinjection 
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(Gordon et al. 1980; Brem et al. 1985; Hammer et al. 1985). For the implementation, 
purified DNA is direct injected mostly into male pronucleus of fertilized oocytes. The 
limitations of the method are the low efficiency and enormous cost. In mice, 1-3% of 
microinjected embryos become transgenic (reviewed in Houdebine 2005) and less 
than 1% of transgenic livestock were obtained per injected zygote (reviewed in Robl 
et al. 2007).  
 
2.2.2  Sperm-mediated gene transfer 
 
Another possibility to introduce foreign DNA into animal genomes is the sperm-
mediated gene transfer (SMGT). Brackett et al. (1971) demonstrated first the 
transport of exogenous DNA into the oocyte via sperm cells. In pig a very efficient 
DNA transfer was achieved with up to 80% transgenic offspring (Lavitrano et al. 
2002). Although, SMGT is simple and costs are low, there are some drawbacks. Robl 
et al. (2007) reviewed difficulties in reproducibility, which means lab and species-
dependent variations in efficiency.  
An alternative method to produce transgenic animals is the intracytoplasmatic sperm 
injection (ICSI) mediated gene transfer which was established by Perry et al. (1999). 
They reported that incubated mouse spermatozoa with foreign DNA were 
microinjected into the cytoplasm of oocytes by ICSI. Kurome et al. (2006) 
demonstrated that ICSI-mediated gene transfer is an efficient and practical method to 
generate transgenic pigs. 
 
2.2.3  Viral transgenesis 
 
Retroviruses have an RNA genome, which is reverse transcribed into DNA using 
reverse transcriptase in host cells. Next, the DNA is incorporated into the host 
genome by integrase and is replicated and transcribed into mRNA. Currently, 
numerous transgenic animals were generated using retroviral vectors. For the creation 
of transgenic animals two types of retroviral vectors have been developed. One group 
is formed by vectors which derived from the genome of prototypic retroviruses, such 
as Moloney leukemia viruses (MLV). The other group are vectors which were 
deduced from the genome of more complex retroviruses, for example lentiviruses 
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(reviewed in Robl et al. 2007). The advantage of lentiviral vectors compared to the 
prototypic retroviruses is the active transport of the genome into the nucleus. 
Therefore, transgenesis of non-dividing cell types is possible (Follenzi et al. 2000). In 
farm animals 70% carried the lentiviral vector and 65% expressed the transgene in all 
tissues, including germ cells (Hofmann et al. 2003). The efficiency is relatively high 
but certainly there are several difficulties in the use of retroviruses for the creation of 
transgenic animals. The retroviral long-terminal-repeats (LTR) are often silencing the 
transgene or can interfere with mammalian promoters to inhibit or misdirect host gene 
expression (Jahner and Jaenisch 1985; Wells et al. 1999).  
Additional commonly used viral vectors for gene targeting are recombinant 
adeno-associated viruses (rAAV), which are single-stranded DNA viruses. The CFTR 
gene was targeted in porcine fetal fibroblasts (PFFs) with efficiencies of 0.1 to 10.9% 
after viral transduction with rAAV (Rogers et al. 2008b). 
Using viral vectors, disadvantages are the routine generation of high titer stocks for 
the generation of transgenic animals (al Yacoub et al. 2007) and the limited packing 
amount which depends on the kind of viral vector that can carry 4.5 kb - 10 kb of 
foreign material (Hendrie and Russell 2005; reviewed in Robl et al. 2007).  
 
2.2.4  Somatic Cell Nuclear Transfer (SCNT) 
 
Another very common method for the generation of transgenic animals is the somatic 
cell nuclear transfer (SCNT) with genetically modified donor cells. The process of 
SCNT begins with an unfertilized, haploid egg cell, of which the nucleus is extracted 
and replaced by a nucleus from a diploid donor cell (Wilmut et al. 1997). The donor 
cell genome can be modified by gene addition and site-directed modification before 
transfer into enucleated oocytes. Advantages of SCNT are the generation of non-
chimeric animals that possess the genetic background of the donor nucleus. Further, it 
is possible to determine the sex and other characteristics of transgenic founder 
animals in advance and SCNT is the only method produce domestic knockout 
animals (Niemann and Kues 2000). 
2.2.4.1  Overview 
 
The first application of nuclear transfer in mammals was employed by McGrath and 
Solter (1984). They established the technique first in mice. Blastomeres were used as 
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nuclear donors not only in mice (McGrath and Solter 1984), but also for the 
production of lambs (Willadsen 1986), cattle (Robl et al. 1987) and pigs (Prather et 
al. 1989). The successful cloning of an entire mammal, namely “Dolly”, from a 
differentiated adult mammary epithelial cell was revolutionary (Wilmut et al. 1997). 
Later, a lot of different groups showed that cloning is also possible using fetal and 
adult somatic cells in various species, such as cattle (Cibelli et al. 1998; 
Zakhartchenko et al. 1999), mouse (Wakayama et al. 1998), goat (Baguisi et al. 
1999), gaur (Lanza et al. 2000), pig (Polejaeva et al. 2000), mouflon (Loi et al. 2001), 
rabbit (Chesne et al. 2002), cat (Shin et al. 2002), mule (Woods et al. 2003), horse 
(Galli et al. 2003), rat (Zhou et al. 2003) and dog (Lee et al. 2005). 
A widespread use of SCNT is the cloning of high quality farm animals, for instance 
in animal agriculture to improve milk production, wool quality or recreation of 
extinct species and conservation of endangered species (reviewed in Westhusin et al. 
2001 and Vajta and Gjerris 2006). Moreover, the creation of genetically identical 
animals was suggested to be useful for the development of new vaccines (reviewed in 
Wolf et al. 2001).  
Schnieke et al. (1997) generated the first transgenic livestock clones. They used 
transfected fetal fibroblasts for generation of two lambs expressing human factor IX. 
After this great success, a variety of transgenic animals were generated by SCNT, 
which can be used as bioreactors, for instance the production of medically relevant 
proteins (reviewed in Brink et al. 2000 and Houdebine 2000). Another important 
application is the side-directed mutagenesis to generate knock-out animals for 
xenotransplantation and to study human diseases (Lai et al. 2002; Klymiuk et al. 
2011a).  
 
2.2.4.2  Cloning efficiency 
 
In general, the efficiency of SCNT is very low in mammals. Various groups 
calculated the cloning efficiency from the numbers of offspring per transferred 
embryos. The success rate between various mammals and within a species shows a 
wide range: pig: 0.2 to 7% (Polejaeva et al. 2000; Dai et al. 2002), cattle: 4 to 83% 
(Kato et al. 1998; Kishi et al. 2000), sheep: 3 to 18% (Wilmut et al. 1997; McCreath 
et al. 2000) and mouse: 0.5 to 3.7% (Wakayama and Yanagimachi 2001; Dai et al. 
2002). The comparison of cloning efficiency between different animals, but also 
REVIEW OF THE LITERATURE 
- 9 - 
 
within a species is difficult, because different donor cell types and various protocols 
for SCNT are used. 
Furthermore, there is a low birth rate and cloned fetuses and newborns may show a 
variety of pathological abnormalities, for instance circulatory disturbances, 
malformation of kidney and brain, dysfunction of immune system as well as placenta 
edema and dysfunction (Hill et al. 1999; De Sousa et al. 2001; Rhind et al. 2003).  
 
2.2.4.3  Factors influencing the efficiency of SCNT 
 
SCNT consists of several steps that have an impact on the cloning success rate. On 
the one hand, the origin, quality and cultivation of oocytes are important points 
(Piedrahita et al. 2002). On the other hand, somatic cells are isolated from various 
donor animals, hence, they are differ in age (Kasinathan et al. 2001) and tissue origin 
(Kato et al. 2000; Wells et al. 2003). Other important factors are culture conditions 
(Zakhartchenko et al. 1999), cultivations time (Cho et al. 2004), passages (Liu et al. 
2001) and state of differentiation of donor cells (Sung et al. 2006; Kumar et al. 2007). 
Moreover, cell cycle synchronization of donor cells and recipient oocytes (reviewed 
in Kues et al. 2000; Tomii et al. 2009) as well as epigenetic status of donor cells 
(Enright et al. 2003; reviewed in Yang et al. 2007) are a crucial part in successfully 
cloning of animals. During nuclear transfer process a lot of different factors play a 
role, including the method of enucleation (Vajta et al. 2001), activation and fusion 
(Galli et al. 2002) as well as activation and fusion time (Akagi et al. 2003).  
Epigenetic modifications are responsible for specialization of cells during 
differentiation due to modifications of nucleotides and chromatin structures, but do 
not involve a change in the nucleotide sequence (reviewed in Surani 2001). Thereby, 
specific genes, like pluripotency genes are switched off and tissue-specific genes are 
up-regulated and need to be down regulated to achieve a totipotent state in the process 
called reprogramming (reviewed in Tian et al. 2003). The processes of 
reprogramming of epigenetic modifications is crucial for dedifferentiation of donor 
nuclei during SCNT, which affects DNA methylation, histone modification, telomere 
length, X chromosome inactivation as well as genome imprinting (reviewed in Shi et 
al. 2003). It is presumed that the low cloning efficiency is largely attributable to the 
incomplete and faulty reprogramming of epigenetic modifications, leading to 
abnormal patterns of DNA methylation (Bourc'his et al. 2001; Ohgane et al. 2001), 
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X-chromosome inactivation (Xue et al. 2002) and histone modifications (Enright et 
al. 2003). Furthermore, expression of imprinted and non-imprinted genes is disturbed 
(Bourc'his et al. 2001; Rideout et al. 2001; Dean et al. 2003).   
There are several ways to influence epigenetic modifications. For instance Himaki et 
al. (2010) and Jeseta et al. (2008) demonstrated significantly higher blastocyst rate 
after treatment with histone deacetylase inhibitor Trichostatin A of in vitro cultivated 
porcine embryos and in SCNT embryos using PFFs as donor cells. Furthermore, in 
PFFs silenced transgenes were reactivated after treatment with the DNA 
methyltransferase inhibitor 5-Aza-2´-deoxycytidine and/or with Trichostatin A (Kong 
et al. 2011). 
 
 
2.3  Suitable cell types for nuclear transfer in pigs  
 
The choice of donor cells is very important for successful genetic modification and 
has a great influence on the efficiency of cloning by nuclear transfer. Until now, 
many different types of donor cells have been successfully applied as nuclear donors 
for nuclear transfer who can be classified into two groups: pluripotent stem cells and 
somatic cells, including multipotent stem cells and differentiated cells.  
 
2.3.1  Pluripotent stem cells  
 
Embryonic stem (ES) cells are pluripotent stem cells that are able to differentiate into 
cells of the three germ layers: endoderm, ectoderm and mesoderm. Though, they lack 
the potential to form trophoblasts and cannot develop into extraembryonic tissue, like 
totipotent stem cells which occur in the zygote up to 8-cell-stage of an embryo 
(reviewed in Leo and Grande 2006). Nuclear transplantation of inner cell mass (ICM) 
cells into enucleated zygote was carried out first in mice by Illmensee and Hoppe 
(1981). Later, donor cells of a 2-cell to 16-cell embryo were transferred into an 
enucleated metaphase II oocyte in sheep (Willadsen 1986), cattle (Prather et al. 
1987), pig (Prather et al. 1989) and rabbit (Collas and Robl 1990). 
Pluripotent definitive ES cells are isolated from morulae or inner cell mass of a 
blastocyst, which were first isolated in mice (Evans and Kaufman 1981; Martin 1981) 
and have been used successfully for cloning several times. Furthermore, it has been 
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demonstrated that in mice cloning efficiency using ES cells is 10- to 20-fold higher 
than with somatic donor cells, like fibroblasts and cumulus cells (Rideout et al. 
2001). So far, ES cells have been isolated not only from mouse, but also from rat 
(Ueda et al. 2008), human (Thomson et al. 1998) and monkey (Thomson et al. 1995). 
Certainly, definitive ES cells have not yet been isolated from livestock species. Due 
to difficulties in pig ES cells cultivation, missing suitable feeder layers and quickly 
differentiation, it is necessary to look for other alternatives (reviewed in Vackova et 
al. 2007).  
An alternative could be the application of induced pluripotent stem (iPS) cells. 
Takahashi and Yamanaka (2006) described the reprogramming of murine fibroblasts 
into iPS cells, which was achieved by retroviral transduction of the transgenes c-myc, 
klf4, sox2 and oct3/4. Various laboratories generated porcine putative iPS cells and 
verified standard criteria for pluripotency, including the ability to differentiate along 
multiple tissue lineages and differentiate into teratomas composed of the three germ 
layers after injection into nude mice, but there was a lack in germ line competence of 
these cells (Esteban et al. 2009; Ezashi et al. 2009; Wu et al. 2009). A major 
disadvantage of iPS cells is their potential of tumor formation due to the reactivation 
of the c-myc transgene which was shown in mice (Okita et al. 2007; Miura et al. 
2009). However, in the last years various methods were developed to avoid this 
negative effect of c-myc and klf4 in mice and human (reviewed in Nowak-Imialek et 
al. 2011). In summary, it is difficult to predict, if iPS cells can replace embryonic 
stem cells and whether they are suitable for the generation of animals. 
 
2.3.2 Somatic cells 
 
Multipotent also called adult stem cells are found throughout the body and have the 
potential for self-renewal and generation of multiple but limited number of lineages 
(Hwang et al. 2005). They are very important in the repair system and maintenance of 
tissue homeostasis (reviewed in Caplan and Bruder 2001).  
Several multipotent stem cell types were used in pigs for SCNT experiments, for 
instance skin stem cells (Zhu et al. 2004) as well as mesenchymal stem cells (MSCs) 
from bone marrow (Bosch et al. 2006) and peripheral blood (Faast et al. 2006). 
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Kato  et al. (2004) and Colleoni et al. (2005) showed that bovine and porcine MSCs 
derived from bone marrow are suitable for genetic modifications and SCNT.  
Several groups have investigated whether a less differentiated cell type can increase 
the efficiency of SCNT. They have shown in pig that MSCs derived from bone 
marrow as nuclear donor for SCNT resulted to twofold higher percentage of embryos 
that developed to the blastocyst stage than adult ear fibroblasts (Faast et al. 2006) and 
fetal fibroblasts (Jin et al. 2007; Kumar et al. 2007), respectively. In addition, Kumar 
et al. (2007) demonstrated in pig that MSCs derived embryos were more similar to 
in vivo embryos compared to fetal fibroblasts, regarding to expression of key 
embryonic genes like OCT4/NANOG as well as DNA methylation, histone 
deacetylation and additional gene expression patterns. 
Usually, isolated MSCs are characterized after isolation and the multilineage 
differentiation potential should be shown by adipogenic, osteogenic and chondrogenic 
development and immunocytochemical analysis before usage (Bosch et al. 2006; 
Faast et al. 2006). It has to be emphasized that the culture and differentiation of these 
stem cells is costly due to required growth factors. 
 
In recent years, cloning was very successful with differentiated somatic cells, 
although they have a limited lifespan (reviewed in Kuilman et al. 2010) and 
reprogramming after nuclear transfer is challenging. For expansion, transfection, 
selection and screening of genetically modified primary sheep fetal fibroblasts 45 
population doublings are necessary (Clark et al. 2000). Therefore, not all somatic cell 
types are suitable for the generation of transgenic animals, because of their limited 
capacity for replication and consequent growth arrest, resulting in cellular senescence 
(Hayflick 1965). Leonard Hayflick and Paul Moorhead (1961) discovered that human 
diploid cell strains cannot divide indefinitely, but die after a certain number of 
divisions (approximately 60-80 cell divisions), which is known as the Hayflick limit. 
In mammals, various laboratories achieved relatively high efficiencies in SCNT using 
donor cells from female reproductive system, for instance mammary gland (Wilmut et 
al. 1997), oviduct (Kato et al. 1998) and cumulus/granulosa cells (Wakayama et al. 
1998; Wells et al. 1999). Also donor cells from male reproduction such as Sertoli 
cells were successfully used for SCNT (Ogura et al. 2000). In addition, cloned 
animals have been generated from kidney cells (Yin et al. 2002), mature B and T 
cells (Hochedlinger and Jaenisch 2002) as well as muscle cells (Green et al. 2007). 
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Widely used somatic cell types for cloning and generation of transgenic animals are 
fetal and adult fibroblasts of sheep (Schnieke et al. 1997), mouse (Wakayama and 
Yanagimachi 1999), bovine (Trounson et al. 1998; Kubota et al. 2000) and pig 
(Betthauser et al. 2000).           
 
 
2.4  Genetic modifications  
 
Depending on the question that is addressed to the transgenic pig model, donor cells 
are modified using additive gene transfer, where the modification is achieved by 
random integration of an expression vector into donor genome or by site-directed 
gene modification, also known as gene targeting (Thomas et al. 1986). 
 
2.4.1  Additive gene transfer  
 
The random insertion of a gene of interest into the genome is termed additive gene 
transfer. After transfer of a vector into a donor cell, a transient high level of gene 
expression can be observed (transient expression). This expression is limited due to 
dilution of the vector with each cell division and degradation processes.  
A rare event is the integration of the vector into the genome of the donor cell (stable 
expression) (Yano et al. 1991). Stable transfected cells can be generated using a 
vector including a selection cassette. The addition of a gene into the genome is a 
random integration and consequently uncontrollable in both integration site and copy 
numbers of transgenes (Clark et al. 2000; reviewed in Robl et al. 2007). Multiple 
copies of vectors may integrate in the same location (concatemer) as well as at 
different loci. Moreover, a variation in expression levels may occur due to position 
effects. Positional effects are a result of chromatin status of neighboring DNA, which 
can be present in an open (for transcription factors accessible) or in a closed (not 
accessible) structure (Clark et al. 1994; reviewed in Wolf et al. 2000). This can also 
cause the variation of expression levels during development of an organism, in which 
high expression levels are occurred in embryogenesis, but repression of transgene in 
the adult organism. Further, the random integration of transgene may cause 
mosaicism, disruption of functional endogenous sequences and insertion mutagenesis 
with position effects (reviewed in Wolf et al. 2000 and Robl et al. 2007). 
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In the following, one possibility to generate transgenic pigs by additive gene transfer 
and SCNT is described and shown in figure 2. Cultured donor cells are transfected 
with a vector containing the gene of interest and a selectable expression vector. After 
selection stable transfected cell clones are pooled, used for SCNT, followed by 
transfer of the embryos to synchronized recipients. The resulting transgenic fetuses or 
offspring are individual founders with possible different expression levels due to 
pooling of the cell clones. Therefore, fetuses or tissues have to be investigated for 
integration and gene expression. After determination of the animal with the most 
suitable expression level of the transgene, cells of this animal are used for an 
additional cloning round to obtain offspring of animals with the same transgenic 
background.  
 
 
Figure 2: Generation of transgenic pigs by additive gene transfer and SCNT  
The workflow for effective generation of transgenic pigs using an expression vector which was 
transfected and selected in donor cells is shown. These cells were used for SCNT and embryo transfer 
(ET). The received founder animals (fetuses or offsprings) were characterized and cells of the animal 
with suitable expression properties are used for recloning. (Aigner et al. 2010) 
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In addition to the widely used expression vectors for additive gene transfer, it is also 
possible to use mobile genetic elements, so-called transposons. Transposable 
elements are mobile DNA elements which were first studied by Barbara McClintock 
(1950). These elements can be applied as genetic vectors for genome manipulation 
and were successfully applied in various organisms such as drosophila (Thibault et al. 
2004), mouse (Dupuy et al. 2002) and rat (Kitada et al. 2007). The advantages of 
transposon technology in comparison to conventional vectors are the efficient 
integration into the genome, no formation of concatemers and the possibility to 
integrate only one copy into the genome (reviewed in Henikoff 1998; Ivics et al. 
2009). On the other hand, there is a wide variety of transposable elements and it is 
complex and time consuming to find the appropriate system and optimize them 
(Flutre et al. 2011). 
 
2.4.2 Gene targeting 
 
Gene targeting can be achieved in donor cells by site-directed modification which is 
feasible in different ways, for instance by homologous recombination (HR) with 
conventional targeting and BAC vectors as well as zinc-finger-nucleases (ZFN) and 
novel designer nucleases called (transcription activator-like effector 
nucleases - TALENs) or by combination of HR and designer nucleases technology. 
 
2.4.2.1 HR using conventional vectors and BAC-technology 
 
Gene targeting mediated by homologous recombination is a process in which a DNA 
molecule becomes introduced into a cell and the corresponding homologous 
chromosomal section is replaced by the introduced DNA molecule (reviewed in 
Porteus and Carroll 2005). This is a precise application to establish changes in the 
genome. In primary mammalian cells, gene targeting is limited by low efficiency, due 
to high selection effort and rare incidence of HR, while random integration occurs 
more frequently (Alwin et al. 2005). Gene targeting was first accomplished in 
mammalian cells at the human β-globin gene using a targeting plasmid (Smithies et 
al. 1985). Those targeting plasmids have been often used successfully in gene 
targeting experiments including in mice (Gordon et al. 1980), pig (Manzini et al. 
2006) and cattle (Iqbal et al. 2009). 
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Large vectors with increased length of homologous arms between the DNA sequence 
of targeting vector and genome target locus were used to improve efficiency of HR in 
mouse embryo-derived stem cells (Deng and Capecchi 1992). BACs (bacterial 
artificial chromosomes), YACs (yeast artificial chromosomes) and PACs (P1 derived 
artificial chromosomes) are such large vectors which are able to maintain large DNA 
fragments and may be suitable for gene targeting by HR.  
BACs have prevailed over the other systems, because they are single-copy plasmids, 
capable of maintaining 300 kbp and provide structural stability of maintained DNA, 
are convenient to handle and easy transfectable into cells (Shizuya et al. 1992; 
reviewed in Giraldo and Montoliu 2001). The BAC system was developed from 
Escherichia coli fertility-(F-) factor-based plasmid vectors (Hosoda et al. 1990). 
Normally, BAC vectors were accomplished for the creation of genome libraries of an 
organism. Such libraries were used to sequence the genome of organisms, for 
example in the pig genome project (Humphray et al. 2007). Later it was shown that 
BAC vectors are suitable for various applications including additive gene transfer and 
gene targeting experiments. After addition of a BAC vector into the genome, the gene 
of interest can be expressed independently of integration site under its regulatory 
elements and usually keeps the native gene architecture including all cis-regulatory 
elements as well as exon-intron configurations (Chandler et al. 2007; Hofemeister et 
al. 2011).  
The BAC-based site-directed mutagenesis was first successfully applied in murine 
ES cells (Testa et al. 2003; Valenzuela et al. 2003; Yang and Seed 2003) and seven 
years later also in human ES cells (Song et al. 2010). In 2011 the first knockout pigs 
using primary cells targeted with a BAC vector were generated (Klymiuk et al. 
2011a). Certainly, genetic modifications were difficult to verify by common methods 
for instance PCR and Southern blot analysis, because of long homologous arms 
(Valenzuela et al. 2003). Correct integration site were verified using for instance 
FISH (chromosomal fluorescence in situ hybridization) (Yang and Seed 2003) and 
qPCR (quantitative PCR) (Klymiuk et al. 2011a). 
 
2.4.2.2 Designed nucleases   
 
Gene targeting by designed nucleases uses the endogenous homologous 
recombination machinery of the cell to repair double strand breaks (DSB). DSB can 
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lead to chromosomal changes or cell death and occur naturally in all cell types. The 
cells have many options to repair DSB. The two basic, conserved mechanisms from 
yeast to vertebrates are HR and non-homologous end joining (NHEJ) (reviewed in 
Sonoda et al. 2006). Normally, for repair HR uses of DSB the sister chromatid as a 
template for damaged DNA. NHEJ is an incomplete or faulty repair process, which 
frequently causes changes of DNA sequence in the region of the DSB such as 
deletions or insertions of nucleotides (Santiago et al. 2008). DSBs can also arise 
spontaneously by activity of reactive oxygen species (ROS) during normal 
metabolism, at random by ionizing radiation or specific by designed nucleases 
(reviewed in Wu et al. 2007). 
In recent years, designed nucleases have become more and more popular in gene 
targeting next to BAC technology. These nucleases induce artificial DSB at the 
desired locus for site-directed mutagenesis in the genome. The repair mechanism of 
the cells rejoined the DSB by NHEJ, which often introduces insertions or deletions 
that create targeted gene knockouts. In the presence of a DNA template with 
homologous regions, the repair by HR could be increased and incorporation of the 
template into the genome could be achieved (Urnov et al. 2005). 
One of the first artificial nucleases was the zinc-finger-nuclease (ZFN). ZFNs consist 
of a row of designed zinc-finger-proteins which recognize and bind to a specific 
DNA-sequence of <18 bp. The sequence-independent endonuclease FokI is coupled 
on the C-terminal site of the zinc-finger-protein (ZFP) and is able to cut the DNA 
(Durai et al. 2005; reviewed in Porteus and Carroll 2005). The development and 
production of appropriate ZFN is difficult and fault-prone, because sequence context 
and mutual influence is important (Mandell and Barbas 2006). ZFN which were not 
able to recognize the specific DNA target sequence, bind unspecific to the genome 
and generate undesired DSB. These random DSB are the cause of the cytotoxicity 
(reviewed in Wu et al. 2007). Nevertheless, site-directed mutagenesis mediated by 
ZFN was achieved in fruit flies (Bibikova et al. 2002), zebra fish (Doyon et al. 2008) 
and rats (Geurts et al. 2009). Moreover, this technology was applied successfully in 
pig (Whyte et al. 2011) and in addition a homozygote knockout of an endogenous 
gene (GGTA1) was succeeded  (Hauschild et al. 2011).  
Novel designer nucleases based on transcription activator-like effector (TALE) 
protein, which are produced by plant pathogens in the genus Xanthomonas and can 
bind effector specific DNA sequences (reviewed in Bogdanove et al. 2010). 
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Generation of site-specific DSBs were achieved by TALE chimeric nucleases 
(TALENs) in yeast, mammalian and plant cells (Mahfouz and Li 2011). The 
advantages of TALENs are their robust nuclease activity as well as low cytotoxicity 
(Christian et al. 2010). 
 
2.4.3 Selection systems 
 
 
Non-homologous recombination and random integration occurs more frequent than 
homologous recombination. Nevertheless, a suitable selection system is required for 
all methods to generate cells with stable transgene integration.  
The desired selection cassette can be part of the vector containing the gene of interest 
or can be co-transfected using an additional vector. Positive selection is a frequent 
method for both additive gene transfer and gene targeting experiments. The 
aminoglycoside phosphotransferase gene is a common positive selection marker 
which confers resistance to antibiotics, for instance neomycin, kanamycin and 
geneticin also known as G418. Additional antibiotic resistance genes have been 
widely used routinely, like blasticidin, puromycin as well as hygromycin (reviewed in 
van der Weyden et al. 2002). The advantage of positive selection is the availability of 
various antibiotic resistance genes which can be combined in several vectors. 
Certainly, Pham et al. (1996) has evidenced that selection cassettes reduced the 
normal expression of multiple genes at distances greater than 100 kb from the 
insertion. Therefore, selection cassettes can be excised, if they are flanked by 
recognition sequence for site-specific recombinases such as Cre, FLPe as well as 
ϕC31 (reviewed in Sorrell and Kolb 2005). Due to the possibility to remove the 
selection cassette, the generation of transgenic cell lines and animals without 
selection cassette is practicable and antibiotic resistances can be used several times 
and thus reach a further increase of variations.  
Classical selection markers for a negative selection strategy are the herpes simplex 
virus thymidine kinase, diphtheria toxin A and hypoxanthine guanine phosphoribosyl 
transferase (hprt) (Szybalski 1992; Yagi et al. 1993). These genes avoid random 
integration of a targeting vector, because they are placed outside of one or both of the 
homologous sequence of the transgene. During HR the cassette is lost; otherwise the 
cell dies from the gene product of the negative selection cassette. 
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The positive negative selection (PNS) system is more effective, due the combination 
of an antibiotic resistance cassette in the targeted locus and a negative selection on the 
flank of homologous arm. In the first step, cells are selected based on the integration 
of the targeting vector due to positive selection and in the second step cells are 
selected based on the HR event and the resulting loss of the negative selection 
cassette. Mansour et al. (1988) showed a targeting efficiency of 79% with PNS in 
murine ES cells and 30% targeting efficiency were obtained in a rat fibroblast cell 
line (Hanson and Sedivy 1995). The Nobel Prize in Physiology or Medicine 2007 was 
awarded to Mario R. Capecchi, Sir Martin J. Evans and Oliver Smithies for their 
discoveries of principles for gene targeting in mice including the PNS. 
 
 
2.5  Non-viral gene transfer 
 
The efficiency of additive gene transfer and gene targeting by HR with BAC 
technology or in combination with designed nucleases depends strongly on design of 
appropriate vectors, choice of cells and selection strategy as well as transfection 
method. The spontaneous entrance of DNA into cells is a very inefficient process. 
Therefore, two main categories of non-viral gene transfer techniques were developed 
to transfer DNA into the genome of primary mammalian cells, namely chemical and 
physical transfection. 
 
2.5.1  Chemical transfection 
 
The chemical transfection methods include calcium phosphate precipitation, 
lipofection (based on cationic lipids) and nanofection (combined polymers plus 
nanoparticle). 
Calcium phosphate method is an old, easy and inexpensive transfection method 
discovered by Graham and van der Eb (1973). The principle is based on phagocytic 
absorption of a co-precipitate of DNA and calcium phosphate. Dudek et al. (2001) 
obtained transfection efficiency of 0.5% to 5% in primary neurons. A successful 
transfection requires a very high quality of plasmid DNA, optimization on 
temperature and pH (reviewed in Colosimo et al. 2000). A further improvement can 
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be achieved by treatment of cells with DMSO or glycerol (Kingston et al. 2001). 
Using a modified calcium phosphate transfection method, human chondrocytes were 
transfected with an efficiency of 80% (Qureshi et al. 2008).  
During lipofection, cationic lipids forming liposomes, which spontaneously interact 
with negatively charged DNA and fuse with cell membrane or are absorbed by 
endocytosis into the cells (Felgner et al. 1987; Friend et al. 1996; Matsui et al. 1997). 
Felgner et al. (1987) postulated a 5- to >100-fold increased transfection efficiency of 
lipofection compared with calcium phosphate method depending on the cell line. 
Lipofection requires a thorough optimization for each given cell line, such as cationic 
lipid to DNA ratio, amount and size of DNA as well as incubation time to minimize 
cytotoxicity (Almofti et al. 2003; McLenachan et al. 2007). In general, the method is 
simple and easy to apply on a large scale (Yang and Huang 1997). A lot of different 
groups showed high transfection efficiencies in various cell types, for instance around 
80% in HEK 293 cells, 30% in pig tracheal epithelial cells and 28% in pig fetal 
fibroblasts (Maurisse et al. 2010) as well as approximately 50% in mouse embryonic 
stem cells (McLenachan et al. 2007). 
Nanofection is a chemical transfection method which was developed by PAA 
(Pasching, Austria). The transfection mechanism is based on a positively charged 
polymer which binds the DNA and is embedded into a porous nanoparticle. The 
nanoparticle protects the DNA against nucleases and degradation and further helps 
the DNA to deliver into the cells (PAA 2012). Using Nanofectin, Orth et al. (2008) 
obtained high transgene expression in human chondrosarcoma cell and primary cells 
from human fibrous dysplasia. 
 
2.5.2  Physical transfection methods 
 
Physical transfection methods include microinjection, electroporation, nucleofection 
and biolistic gene transfer. 
The successful microinjection of human cells with solid glass capillaries was first 
shown by Diacumakos et al. (1970). With this method it was possible to verify 
mRNAs, before genes were known or cloned, for instance of interferon and 
thymidine, kinase (Liu et al. 1979). Today, the mechanical transfer of DNA, mRNA, 
small interfering RNAs, proteins, peptides as well as drugs belongs to the wide 
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spectrum of molecules microinjected into single cells (reviewed in Zhang and Yu 
2008a). The advantages are the high transfection efficiency, low cytotoxicity as well 
as precise dosage of injection material. Certainly, major drawbacks are the low 
number of injected cells, the high expenditure of time and laborious work (reviewed 
in Zhang and Yu 2008b).  
Electroporation is based on the usage of an electrical impulse, which disturbs the 
phospholipid bilayer of the membrane and temporarily causes the formation of 
aqueous pores. DNA/RNA-molecules are delivered through the open membrane by 
diffusion into the cell. After the pulse, the cell membrane discharges, pores close and 
the phospholipid bilayer reassembles (Andreason and Evans 1988). For this 
technique, the pioneering work was done by Neumann et al. (1982) and Chu et al. 
(1987). For an efficient transfection many parameters must be adjusted including 
pulse duration and strength, capacity, DNA and cell amount, temperature and buffer 
solution (Baum et al. 1994).  
A further advancement of electroporation is the nucleofection system which was 
developed by Amaxa Biosystem (Cologne, Germany). The optimization of 
nucleofection is easier compared to electroporation, because it combines preset 
electroporation programs with specific nucleofection solutions for the particular cell 
type (Maurisse et al. 2010). This technology is highly efficient for gene transfer into 
most primary cells, especially in slowly dividing or mitotically inactive cells as well 
as hard to transfect cell lines (Gresch et al. 2004). DNA/RNA is directly transported 
into the nucleus (Hamm et al. 2002). The usage of nucleofection system is easy, fast 
and safe, and the transfection efficiency is reproducible (Gartner et al. 2006). It was 
successfully applied to hematological and immunological cells (Lai et al. 2003; 
Martinet et al. 2003), primary neurons (Leclere et al. 2005), embryonic and adult 
stem cells (Lakshmipathy et al. 2004; Lorenz et al. 2004), fetal and adult primary 
mammalian cells (Nakayama et al. 2007; Skrzyszowska et al. 2008) as well as 
transformed mammalian cells and cell lines (Schakowski et al. 2004; Maurisse et al. 
2010). One drawback of both electroporation and nucleofection is the need for 
detachment of adherent cells and the resultant stress (reviewed in Colosimo et al. 
2000). 
Biolistic gene transfer or gene gun is a particle-based transfection method, originally 
designed for plant cell transfection (reviewed in Klein et al. 1992). The DNA is 
linked to inert nanoparticles (commonly gold and tungsten, respectively) and is shot 
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directly into the nucleus of the cells. The advantages of the method are low level of 
cell damage, usage of small amount of DNA and target cells as well as potential 
application for in vivo transfection (Sanford et al. 1993). On the other hand, the 
method has some drawbacks, including high initial cost, poor tissue penetration and 
complex instrument settings such as air pressure, particle size, density as well as 
velocity and distance (Heiser 1994; reviewed in Colosimo et al. 2000). Anyway, 
biolistic gene transfer has been applied in a wide range of plant cells and of animal 
somatic tissues and cells, respectively (Gao et al. 2006; Zindler et al. 2008; 
Hochbaum et al. 2010). 
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3 CELLS, MATERIAL AND METHODS 
 
3.1  Material 
3.1.1  Apparatuses 
 
Centrifuges 
 Biofuge pico  
 Rotanta 96 
 Centrifuge 5417R 
Finnpipette
®
 Multichannel pipette (300 µl) 
GFL 3031 shaker 
Incubators 
 
Microscopes and Camera 
 Leica DM IL 
 Zeiss Axiovert 200 M fluorescence  
              microscope 
 Axiocam HR 
E.coli pulser electroporation device 
Freezing containers 
 
Micoprocessor pH meter 
Neubauer counting chamber 
Nucleofector 
TM
 II 
Pipettes 
 
Gene Pulser II 
Spectrophotometer Gene Quant 
Steril benches Laminair
®
 HB2448K, 
HB2472 
Sunrise
TM
 microplate reader 
 
Heraeus, Osterode, Germany 
Hettich, Tuttlingen, Germany 
Eppendorf, Hamburg, Germany 
Thermo Fisher Scientific, USA 
Hilab, Düsseldorf 
OMEG, Schöngeising, Germany; 
Memmert, Schwabach, Germany 
 
Leica, Wetzlar, Germany 
Carl Zeiss, Oberkochen, Germany 
 
Carl Zeiss, Oberkochen, Germany 
Bio-Rad, Munich, Germany 
YMC Co., Japan; 
Thermo Fisher Scientific, USA 
WTW, Weilheim, Germany 
Assistant, Sondheim, Germany 
Lonza, Basel, Switzerland 
Gilson Inc., USA, 
Eppendorf, Hamburg, Germany 
Bio-Rad, Munich, Germany 
GE Heathcare, Munich, Germany 
Heraeus, Osterode, Germany 
 
Tecan GmbH, Salzburg, Austria 
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3.1.2  Chemicals 
 
All chemicals were used in p.a. quality, if not stated otherwise. 
 
Acetic acid (glacial) (HOAc) 
Agar-agar 
β-Mercaptoethanol 
DAPI (4´,6-diamidino-2-phenylindole) 
DMSO (Dimethylsulfoxid) 
EDTA (Ethylenediaminetetraacetic acid) 
Ethanol (EtOH)  
Glucose  
HEPES 
Methanol 
Mineral oil 
Phenol red 
Potassium chloride (KCL) 
di-Potassium hydrogen phosphate 
(KH2PO4) 
Sodium becarbonate (NaHCO3) 
Sodium chloride (NaCl) 
Sodium hydroxide (NaOH) 
di-Sodium hydrogen phosphate (Na2HPO4) 
di-Sodium hydrogen phosphate × dihydrate 
(Na2HPO4×2H2O) 
mono-Sodium phosphate (NaH2PO4) 
Orcein 
Tryptone/Peptone 
Yeast extract 
Merck, Darmstadt, Germany 
Roth, Karlsruhe, Germany 
Sigma-Aldrich, Steinheim, Germany 
Sigma-Aldrich, Steinheim, Germany 
Sigma-Aldrich, Steinheim, Germany 
Roth, Karlsruhe, Germany 
Roth, Karlsruhe, Germany 
Sigma-Aldrich, Steinheim, Germany 
Sigma-Aldrich, Steinheim, Germany 
Roth, Karlsruhe, Germany 
Roth, Karlsruhe, Germany 
Sigma-Aldrich, Steinheim, Germany 
Sigma-Aldrich, Steinheim, Germany 
Roth, Karlsruhe, Germany 
Sigma-Aldrich, Steinheim, Germany 
Roth, Karlsruhe, Germany 
Roth, Karlsruhe, Germany 
Roth, Karlsruhe, Germany 
Fluka, Neu-Ulm, Germany 
 
Sigma-Aldrich, Steinheim, Germany 
Sigma-Aldrich, Steinheim, Germany 
Roth, Karlsruhe, Germany 
Roth, Karlsruhe, Germany 
 
3.1.3  Cell Culture 
 
Collagenase II 
CollagenR 
 
Life Technologies, Karlsruhe, Germany 
Serva, Heidelberg, Germany 
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3.1.4 Consumption and other working material 
 
Cryotubes (1.0 ml, 2.0 ml) 
 
Cell culture dishes (10 cm, 6 cm, 3.5 cm) 
Cell Strainer 100 µm 
Centrifuge Tubes (15 ml, 50 ml) 
Glass pipettes 
Multi-well-plates  
 6-well, 12-well, 96-well F-bottom 
 24-well, 48-well 
Parafilm
®
M 
Pipette tips 
Pipette tips with filter 
Reaction tubes (1.5 ml, 2.0 ml) 
Serological pipettes Cellstar
®
 
SS35 50 ml centrifuge tubes 
PAA, Pasching, Austria 
Nunc, Wiesbaden, Germany 
Sarstedt, Nümbrecht, Germany 
BD Falcon, Heidelberg, Germany 
BD Falcon, Heidelberg, Germany 
Hirschmann, Eberstadt, Germany 
 
Greiner bio-one, USA 
Nunc, Wiesbaden, Germany 
American Can Company, USA 
Eppendorf, Hamburg, Germany 
Axygen Inc., USA 
Eppendorf, Hamburg, Germany 
Greiner bio-one, USA 
Eppendorf, Hamburg, Germany 
DMEM (Dulbecco modified Eagle    
    Medium) High glucose  
FCS (Fetal calf serum) 
Gelatine 
Hanks´BSS (HBSS)  with Ca
2+
/Mg
2+
 
Hyaluronidase 
Karyomax (Colcemid) 
L-Glutamin (200 mM) 
L-Glutamin + Penicillin/Streptomycin 
(100x) 
Non-essential amino acids (100x) 
Sodium pyruvate 
Trypanblau 
Trypsin Difco
TM
 250 
Vectashield (DAPI) Mounting Medium 
Life Technologies, Karlsruhe, Germany 
 
Life Technologies, Karlsruhe, Germany 
Sigma-Aldrich, Steinheim, Germany 
PAA, Pasching, Austria 
Sigma-Aldrich, Steinheim, Germany 
Life Technologies, Karlsruhe, Germany 
PAA, Pasching, Austria 
PAA, Pasching, Austria 
 
Life Technologies, Karlsruhe, Germany 
Life Technologies, Karlsruhe, Germany 
Sigma-Aldrich, Steinheim, Germany 
BD Falcon, Heidelberg, Germany 
Vector Laboratories, Burlingame, USA 
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Sterile filter 
 Steritop GP 0.22 µm Express® plus  
             membrane 
 Sterivex GP 0.22 µm 
 
 
 
 
 
 
 
 
Millipore, USA 
 
 
 
 
 
 
Millipore, USA 
 
3.1.5  Kits 
 
Amaxa
TM
 Basic Nucleofector
TM
 Kit 
for Primary Mammalian Fibroblasts  
Electroporation Buffer + Cuvettes (0.4 cm) 
E.Z.N.A
TM
 Endo-free Plasmid Maxi Kit 
Fermentas Midi Prep DNA 
Nanofection Transfection Kit 
Lipofectamine LTX, Plus SAM 
MTT-Cell Proliferation Kit I 
Lonza, Basel, Switzerland 
 
Bio-Rad, Munich, Germany 
Omega, USA 
Thermo Fisher Scientific, USA 
PAA, Pasching, Austria 
Life Technologies, Karlsruhe, Germany 
Roche Diagnostics, Basel, Switzerland 
 
3.1.6  Antibiotics and antimycotics 
 
Amphotericin B  
Blasticidin S 
Geneticin (G418) 
Kanamycin 
Penicillin/Streptomycin 
PAA, Pasching, Austria 
PAA, Pasching, Austria 
Life Technologies, Karlsruhe, Germany 
Roth, Karlsruhe, Germany 
PAA, Pasching, Austria 
 
3.1.7  Culture media and supplements for cell culture 
 
Millipore machine deionized water called ddH2O was used as solvent, if not stated 
otherwise. Culture media, supplements including FCS for cell culture were 
filter-sterilized (0.22 µm pore size) before use and stored at 4°C. 
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Culture media for PKC, PEF and PFF  
DMEM with 
FCS 
non-essential amino acids (100 x) 
L-Glutamine (200 mM) with    
    penicillin/streptomycin (100 x) 
sodium pyruvate 
β-Mercaptoethanol 
 
10 % or 15 % (v/v) 
1 % (v/v) 
1 % (v/v) 
 
1 % (v/v) 
0.1 mM 
 
Cryopreservation medium 
FCS 
DMEM 
90 % (v/v) 
10 % (v/v) 
 
EGTA buffer 
NaCl 
KCl 
NaH2PO4 
Na2HPO4 2H2O 
HEPES 
glucose 
NaHCO3 
phenol red 
28 mM 
1 mM 
0.14 mM 
0.12 mM 
2 mM 
1 mM 
0.8 mM 
40 µl 
 
Chemicals were solved in ddH2O and NaHCO3 was added at the end. The pH of 7.2 
was adjusted with 5 M NaOH. The buffer was stored at 4°C for maximum three 
months.  
 
FCS (fetal calf serum) 
Before use, FCS was heat inactivated. Therefore, FCS was incubated for 30 min at 
56°C, sterile filtered, aliquoted and stored at -20°C. 
 
LB medium 
yeast extract 
trypton/pepton 
NaCl 
5 g 
10 g 
2.5 g 
Ad 1000 ml ddH2O 
pH7.0 (adjust with 5 M NaOH) 
LB medium was autoclaved and stored at RT. 
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LB-agar plates 
yeast extract 
trypton/pepton 
NaCl 
5 g 
10 g 
5 g 
ad 1000 ml ddH2O. 
pH 7.0 (adjust with 5 M NaOH) 
agar-agar 15 g 
LB-agar medium was autoclaved and cooled down to 60°C. 1 ml of kanamycin 
(25 mg/ml) was added to LB-agar medium. Medium was poured into culture plates, 
allowed to solidify and subsequently stored at 4°C. 
 
PBS (Phosphate buffered saline, pH 7.2-7.4) w/o Ca
2+
 and Mg
2+
 
NaCl 
Na2HPO4 
KCl 
KH2PO4 
136 mM 
8.1 mM 
2.7 mM 
1.5 mM 
After sterile filtration PBS was stored at RT or 4°C. 
 
Starvation medium 
DMEM with 
FCS 
non-essential amino acids (100 x) 
sodium pyruvate (100 x) 
L-Glutamine (200 mM) 
 
0.5 % (v/v) 
1 % (v/v) 
1 % (v/v) 
1 % (v/v) 
 
Stop medium 
DMEM 
FCS 
90 % (v/v) 
10 % (v/v) 
 
Trypsin/EDTA 
PBS w/o Ca
2+
 and Mg
2+
 with 
Trypsin 
EDTA 
 
0.5 % (w/v) 
0.04 % (w/v) 
 
After sterile filtration, aliquots were stored at -20°C. 0.4 % Trypsin/EDTA solution 
was used for PKC and 0.1 % for PEF and PFF cell cultures. 
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3.1.8 Plasmid 
 
pmaxGFP
TM
 Lonza, Basel, Switzerland 
 
3.1.9 Bacterial strain 
 
TOP10 Life Technologies, Karlsruhe, Germany 
 
 
3.1.10 Software 
 
Axio Vision 4.2 
WCIF ImageJ 1.34s 
 
 
Magellan Software 
Zeiss, Oberkochen, Germany 
National Institutes of Health 
(http://rsb.info.nih.gov/ij/), Bethesda, 
USA 
Tecan Austria GmbH, Salzburg, Austria 
 
 
 
3.2  Methods 
 
3.2.1  Cell Culture 
 
The cell culture work was performed under the laminar flow hood. The cells were 
cultured at 37°C and 5% CO2 in a humidified atmosphere. The media were warmed 
before use in a water bath at 37°C.  
In general, PKCs were cultured in medium containing 10% FCS, except after 
transfection and selection when cells were cultured in 15% FCS. PFFs and PEFs were 
always cultured in 15% FCS culture medium. 
All cells were cultured onto collagen coated plastic dishes. The collagen was solved 
1:10 with ddH2O and the culture dishes were incubated over night at RT.  
 
3.2.1.1  Isolation of primary cells (PKCm, PKC2109, PEF0110 and PFF26) 
 
The wild-type cells were isolated from different pigs (Tab.1). The isolation of PKCm 
and PFF26 was carried out by Dr. Annegret Wünsch.  
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Table 1: Wild-type cells isolated from different pigs 
Name Cell type Breed  Age  
Kidney m 
 
Kidney 2109 
 
PEF 0110 
 
PFF 26 
PKC 
 
PKC 
 
PEF 
 
PFF 
German Landrace 
 
German Landrace 
 
German Landrace 
 
Swabian-Hall 
~3 month 
 
~3.5 month 
 
a few days 
 
abort: day 27 
 
PKC=Porcine kidney cells, PEF=Porcine ear fibroblasts, PFF=Porcine fetal fibroblasts 
 
Different centrifugation settings were used; PKCm, PKC2109: 5 min at 180×g; 
PEF0110: 10 min at 180×g and PFF26: 5 min at 140×g. 
The protocols for isolation of PKC and PEF were partially the same. Tissue pieces 
(kidney 2×1×1 cm, ear 0.5×0.5 cm) were stored in washing buffer (PBS with 
1× Pen/Strep and 1× Amphotericin B) in refrigerator or on ice. Tissue was washed 
twice in washing buffer, minced and suspension was washed with DMEM until the 
supernatant became clear. Subsequently, the protocols are distinguished between the 
different cell types. 
The pelleted PKCm tissue was resuspended in 15 ml 0.1% (w/v) collagenase solution 
in HBSS and incubated at 37 °C for 2 h, while shaking once every 15-29 min. After 
digestion, flask was filled up to 50 ml with DMEM. Tissue pieces were allowed to 
settle down and supernatant was collected. The remaining pieces of tissue were 
digested again with 0.5% trypsin/0.04% EDTA solution in PBS for 20 min at 37°C. 
Afterwards, digested tissue pieces and collected supernatant were combined and filled 
up to 50 ml with DMEM. 
In case of PKC2109 and PEF0110 pelleted tissue pieces were resuspended in 15 ml 
0.1% (w/v) collagenase solution in HBSS and incubated at 37 °C while stirring. The 
kidney was digested 1 to 1.5 h and the ear 2 h. After incubation, flasks were filled up 
to 50 ml with DMEM. 
Afterwards, PKCm, PKC2109 and PEF0110 cell suspensions were filtered through a 
100 µm mesh and washed with DMEM until the supernatant became clear. 
Depending on pellet size, the amount on seeded cells varied after centrifugation: 1/6 
to 1/24 of resuspended PKC were seeded per 100 mm petri dish and all resuspended 
PEF were seeded onto 6-well to 60 mm petri dish.  
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For the isolation of PFF26, the backbone of a 27 days old fetus was prepared by 
removing head, legs and internal organs. It was washed 3 times in PBS containing 
1× Pen/Strep, minced and washed twice in DMEM. Tissue was resuspended in EGTA 
buffer and incubated rotating in front of infrared lamp at 37°C for 33 min. 
Afterwards, tissue pieces were centrifuged, resuspended in a collagenase (1 mg/ml) 
and hyaluronidase (1 mg/ml) DMEM solution and incubated for 20 min at 37°C. 
After centrifugation, tissue pieces were incubated in 1 mg/ml dispase DMEM 
solution and digested for 40 min at 37°C. Subsequently, tissue pieces were 
centrifuged, resuspended in DMEM, filtered through a tea strainer and washed twice 
in DMEM. After a last centrifugation step, cell pellet was resuspended in culture 
medium and seeded onto a 100 mm petri dish.  
 
3.2.1.2  Subculture of cells 
 
An overview about used culture vessels and amounts of used growth and stop 
medium/PBS, trypsin/EDTA and coating solution is summarized in table 2.  
 
Table 2: Overview of used culture vessels 
Description Area [cm
2
] 
Growth/Stop 
medium/PBS [ml] 
Trypsin/EDTA 
[µl] 
Coating 
solution [µl] 
100 mm 57 10 1500 1500 
60 mm 21.5 5 750 750 
6-well 9.6 2 300 400 
12-well 3.9 1.5 200 250 
24-well 1.9 1 150 200 
48-well 1.1 0.4 80 100 
96-well 0.33 0.1 30 40 
 
At a confluence between 80-100% cells were passaged to expand the cell population. 
Therefore, medium was removed and cells were rinsed two times with PBS. 
Following, cells were incubated with trypsin-EDTA solution at 37°C for 5-7 min. 
Then, cells were collected with stop medium, transferred into a 15 ml tube and 
centrifuged at 180×g for 5 min. Finally, supernatant was removed, cells were 
resuspended in culture medium and a part of the cells were sowed onto new culture 
dishes. The split ratio of the cells was between 1:2 and 1:4 depending on confluence 
and growth potential of the cells. 
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3.2.1.3  Counting of cells 
 
Cells were seeded with a defined cell number of 1.2-1.6×10
3
 cells/cm
2
 depending on 
cell type and constitution of cells onto culture dishes. Cells were counted in a 
Neubauer counting chamber after trypsinization. 
 
3.2.1.4  Cryopreservation of cells 
 
Confluent cells were frozen in liquid nitrogen at -176°C for long term storage. For 
cryopreservation of cells the same procedure as above (see 1.3.1.2) was carried out. 
The difference is that after centrifugation, cell pellet was resuspended in 
cryopreservation medium. Normally, up to 1x10
7
 cells per ml were cryopreserved. 
The cells were aliquot in cryo vials, transferred in freezing container, which cools 
down the samples at a rate of -1°C per minute, and kept at -80°C overnight. After 24 
h cryo vials were transferred to liquid nitrogen.  
Cell clones prepared during gene targeting experiments (see 4.2.2.) were 
cryopreserved as follows: cells were washed twice with PBS, trypsinized and the 
reaction was stopped using 170 µl of cryopreservation medium. The cell suspensions 
was transferred to 1.5 ml reaction tube and put into freezing container in -80°C 
overnight.  
 
3.2.1.5  Thawing of cells 
 
Cryopreserved cells were taken out of liquid nitrogen and put for 1 to 2 min at 37°C. 
Cells were transferred into 15 ml tube containing stop medium and pelleted (180×g, 
5 min). After removing the supernatant, cells were resuspended in an appropriate 
volume of culture medium and were seeded onto culture dishes. 
 
3.2.1.6  Chromosome preparation 
 
Cells with 60-90% confluence were arrested in metaphase by adding final 
concentration of 10 µg/ml colcemide and followed by incubation of 1 h at 37°C. 
Subsequently, cells were trypsinized and centrifuged (8 min, 180×g), medium was 
removed but 0.5 - 1 ml were left and cell pellet was resuspended by strong tapping. 
Then, 13 ml of pre warmed KCL (37°C) was added slowly to the cell suspension, 
gently mixed by inverting, incubated for 15 min at 37°C and were centrifuged (8 min 
ANIMALS, MATERIAL AND METHODS 
- 33 - 
 
at 180×g). Ice-cold, freshly prepared fixative (75% methanol, 25% glacial acetic acid) 
was added slowly with constant gentle shaking of the tube and incubated for at least 
2 h at -20°C. Following, cells were centrifuged for 10 min at 180×g, supernatant was 
removed until 1 ml left, and cells were resuspended and transferred to a 2.0 ml 
reaction tube. The suspension was washed four to five times with fixative (4°C, 4 min 
and 400×g) and chilled at -20°C. Slides were cleaned with ddH2O as well as 70% 
ethanol and were pre warmed to 54°C. 17 µl of suspension were dropped to the slides 
from a height of one meter and slides were tried. 
For analysis, cells were embedded by adding 2-3 drops of Vectashield with DAPI, the 
coverslip was sealed with nail polish and the samples were analyzed by microscopy 
or stored at 4°C. An inverted epifluorescence microscope (Axiovert 200M) equipped 
with filter sets for DAPI (#01, excitation: band-pass filter 365/12 nm, emission: long-
pass filter 397 nm) was used for microscopically analysis. 
PKCm (P3) and PFF26 (P5) were prepared and analyzed by Dr. Annegret Wünsch, 
Tanja Jäger and Pauline Fezert. 
 
3.2.1.7  MTT-based cell proliferation assay  
 
The MTT-Cell Proliferation Kit I determines the metabolic activity of living cells. 
The assay bases on color reaction to measure the viable cell number which was 
established by Mosmann (1983). Only in living cells, the yellow tetrazole (MTT-(3-
(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) becomes reduced in 
active mitochondria to purple formazan. For this, different cell numbers of PKCm and 
PKC2109, PFF26 and PEF0110 were cultivated in duplicates onto 96-wells with 
100 µl medium per well for 48 h without coating, with collagen and gelatine coating, 
respectively. For collagen coating see section 3.2.1 and for gelatin coating, a 0.1% 
gelatin solution was used and the culture plates were incubated for 2 h at RT. A 
standard curve was used in each experiment for every single cell culture seven 
measuring points were applied: 250-50000 cells per well (PKC2109) and 2500-50000 
cells per well (PKCm, PPP26 and PEF0110). For this, cells were seeded in duplicates 
onto the same plate 4 h before MTT treatment. Then, 10 µl of MTT (0.5 mg/ml) of 
the MTT-Cell Proliferation Kit I were added to each well and plates were incubated 
in the cell incubator for 4 h. Following, 100 µl of the solubilisation solution was 
added to each well and was incubated in the incubator overnight. The formation of 
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formazan crystals was measured by spectrophotometrical absorbance at a wavelength 
of 562 nm using Sunrise
TM
 microplate reader. Analysis of data was processed with 
the Magellan Software. 
 
3.2.1.8  Growth curve and population doubling time 
 
5.5×10
4
 cells of PKCm, PFF26 and PEF0110 cell culture were plated onto 12-well 
plates and cultured under standard conditions. Over five days, three wells of each 
culture were trypsinized and counted every 12 h and the average was used. Population 
doubling was calculated in the section of the exponential growth by the following 
formula: 
                                                    
      
  
 
3.2.1.9  Transfection of cells 
 
At a confluence between 60-90% cells were transfected in P4. The transfection 
efficiency of each method was analyzed 24 h after transfection if not stated otherwise. 
 
3.2.1.9.1 Chemical transfection 
 
For chemical transfections, 3.2×10
4
 of PKC2109 cells were seeded onto each 24-well 
the day before. The cells were transfected with the plasmid pmaxGFP
TM
 to determine 
the transfection efficiency. In some experiments an additional analysis was performed 
after 48 h. 
 
Nanofection 
The Nanofectin Kit was used according to manufacturer’s instructions. For this, 0.5 
or 1.0 µg DNA was added each to 1.2, 2, 3.2 or 4 µl, and 1.5 µg DNA was added to 2 
or 3.2 µl of Nanofectin solution.  
 
Lipofection 
The Lipofectamin LTX + Plus Reagents Kit was used according to manufacturer’s 
instructions. 0.25, 0.5 or 0.75 µg of DNA was diluted in DMEM (5, 10 or 15 ng/µl 
DNA) and mixed thoroughly. The optimized volume of the Plus reagent (0.25, 0.5, 
0.75 or 1 µl) was added to the diluted DNA. Lipofectamin LTX was added in 
different ratios (1:1 – 1:4) to the diluted DNA/Plus solution.  
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3.2.1.9.2 Physical transfection 
 
For physical transfection, cells were transfected either with pmaxGFP
TM
 or 
endotoxin-free purified pmaxGFP
TM
. After transfection, cells were seeded onto 
35 mm or 60 mm petri dishes (depending on cell number) containing pre-warmed 
culture medium. 
 
Electroporation  
For electroporation, PKC2109 cells were washed twice with PBS, trypsinized and 
counted. Then, 0.5 or 1×10
6
 cells were centrifuged for 5 min at 180×g. The pellet was 
washed with PBS and resuspended in 600 µl of either Gene Pulser
TM
 electroporation 
buffer, PBS or DMEM  according to electroprotocols of BIO-RAD (2011) and 
electroporation buffer overview (BIO-RAD 2011). DNA (1, 5, 10 or 20 µg) was 
added to the cell suspension and transferred into a 4-mm gap electroporation cuvette. 
Cells were electroporated with Gene Pulser II using various settings (Voltage: 100 V, 
230 V; High Capacity 500 µF; RT or chilled cell suspension). 
 
Nucleofection 
For nucleofection of PKCm, PKC2109, PFF26 and PEF0110 cell cultures the 
Amaxa
TM
 Basic Nucleofector
TM 
Kit Primary Fibroblasts and the Nucleofector II
®
 
device was used. 0.5 or 1×10
6
 cells were mixed with 1, 2, 5, 10 or 20 µg of plasmid 
DNA and 100 µl nucleofection solution and then nucleofected according to 
manufacturer’s instructions using the recommended nucleofector programs A-23, 
T-16, U-12, U-23 and V-13 for fibroblasts. 
 
Detection of transfection efficiency 
 
24 h and 48 h after transfection, respectively, cells were washed twice in PBS, 
followed by fixation with 4% (m/v) PFA for 20 min at RT in the dark. Fixed cells 
were washed with PBS and covered with PBS for storage at 4°C or used for 
DAPI-staining. For this, cells were incubated with DAPI-Methanol (1 µg/ml) for 
10 min at 37°C. Subsequently, cells were washed with methanol and PBS. Finally, 
the fixed cells were covered with PBS and analyzed by microscopy or stored at 4°C.  
An inverted epifluorescence microscope (Axiovert 200M) equipped with filter sets 
for DAPI (#01, excitation: band-pass filter 365/12 nm, emission: long-pass filter 
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397 nm) and GFP (#13, excitation: band-pass filter 470/20 nm, emission: band-pass 
filter 505-530 nm) was used for microscopically analysis. 
 
3.2.1.10 Detection of appropriate antibiotic concentration for selection 
 
Selection procedure starts to eliminate cells without integrated construct after 
transfection and prevent cells toxic concentrations. To detect the appropriate 
antibiotic concentration, an antibiotic dilution series was tested for each given cell 
culture. 
2×10
5
 cells were seeded onto 6-wells with 15% culture medium. Antibiotics at 
various concentrations were added 24 h later. The selection medium was changed 
every other day. The optimal concentration for further experiments was those, in 
which all cells died within seven days. 
 
3.2.1.11  Somatic cell nuclear transfer and embryo transfer 
 
Cells were thawed, cultured and medium was replaced by starvation medium 48 h 
prior to SCNT. SCNT was performed by Dr. Mayuko Kurome, Dr. Barbara Kessler, 
Dr. Valeri Zakhartchenko and Tuna Güngör as described by Kurome et al. (2006) and 
Klymiuk et al. (2011b). The generated embryos were transferred into estrus 
synchronized gilts (ET) by Dr. Barbara Kessler as published (Besenfelder et al. 
1997). Gilts were controlled regularly after ET by ultrasonic examination for 
conception and monitoring of pregnancy. 
The development competence of cloned embryos after SCNT was analyzed using 
various cell types. After electric fusion and activation of oocytes and primary cells, 
the embryos were cultured in vitro seven days up to blastocyst stage. The embryos 
were fixed with acetic acid/methanol (1:3) and stained the nuclei of embryos with 
1% orcein. The embryos were mounted onto glass slides and counted using an 
inverted microscope. 
 
3.2.1.12  Statistical analyzes 
 
χ
2
-test was used to calculated the rate of embryo development. The mean cell number 
of the embryos was compared using Student´s t-test. 
 
ANIMALS, MATERIAL AND METHODS 
- 37 - 
 
3.2.2 Molecular biology methods 
 
 
The commercial plasmid pmaxGFP
TM
 was amplified and purified to obtain higher 
plasmid concentrations and to compare the efficiency of endotoxin-free prepared 
plasmids with commercial generated plasmids. 
 
3.2.2.1 Heat shock transformation 
 
The plasmid pmaxGFP
TM
 was transformed via heat shock into the competent E.coli 
strain TOP10. The E.coli cells were thawed on ice, 2 µl of 0.5 µg/µl pmaxGFP
TM
 
plasmid (diluted 1:75 with H2O) was added and mixed carefully. Afterwards, cell 
suspension was incubated 20 min on ice, heated at 42°C for 45 sec and placed on ice 
for another 2 min. 1 ml LB medium was added to the heat shocked cells and 
incubated for 45 min at 37°C. Subsequently, cells were centrifuged for 5 min at 
2300×g, pellet was resuspended in 200 µl of the supernatant and plated on LB agar 
plates in two different volumes (1/4 and 3/4) containing 25 µg/ml kanamycin. After 
drying, the agar plates were incubated at 37°C overnight and later stored at 4°C until 
endotoxin free isolation (see 3.2.2.2) 
 
3.2.2.2 Endotoxin free isolation of pmaxGFPTM DNA 
 
For preparation of large scales of pmaxGFP
TM
 plasmid, a preculture (3 ml LB 
medium containing 25 µg/ml kanamycin) was inoculated with one picked colony and 
incubated while shaking at 37°C for 6 h. After incubation, the whole preculture was 
transferred into 150 ml LB medium (containing 25 µg/ml kanamycin) and incubated 
while shaking at 37°C overnight. 
The pmaxGFP
TM
 plasmid was isolated endotoxin free using the E.Z.N.A
TM
 Endo-free 
Plasmid Maxi Kit according the manufacturer´s protocol. 
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4 RESULTS 
 
 
4.1 Evaluation of suitable cell sources for SCNT to generate  
transgenic pigs 
 
For generation of transgenic pigs via SCNT an appropriate donor cell type is 
necessary which is applicable for cell isolation, propagation, transfection, selection 
and in vitro/in vivo development after SCNT. Therefore, PKC, PFF as well as PEF 
cell culture were analyzed according to various aspects, which are explained in the 
following. 
 
4.1.1 Characterization and comparison of PKC, PFF and PEF cell cultures 
 
PKC, PFF and PEF cell cultures were analyzed and compared regarding to their 
morphological properties, growth potential, correct metaphases as well as the usage 
as donors for SCNT and development potential in vitro of cloned embryos. 
 
4.1.1.1 Morphology of cells 
 
The morphology of various cell types was compared and cell behavior was evaluated 
over long periods during cultivation.  
The isolation of porcine primary kidney cells as well as fetal and ear fibroblasts were 
straightforward, efficient and not time consuming. The first microscopically 
characterization of isolated cells was done 24 h after isolation. The kidney cells 
showed 70-100% confluence and exhibited a mixture of different cell morphologies 
including cobblestone and spindle shaped cells (Fig. 3). After isolation of PEFs, the 
yield of obtained cells after seeding is lower compared to kidney cell isolation. In 
PEFs culture, often cell clumps attached from which fibroblasts grow out, but also a 
lot of single cells adhered on the culture plate surface with a confluence between 
40 to 60%. PFFs cell culture showed mainly uniform fibroblast-like morphology with 
a confluence between 60 to 90%. 
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Figure 3: Primary cell culture passage 0 (P0) 24 h after isolation 
(A) Various cell types were visible in a 100% confluent PKC cell culture after 24 h. (B) A typical 
observation after PEFs isolation was that fibroblasts grow out of detached cell clumps. bar = 100 µm 
 
 
The generation of single cell clones with a porcine kidney cell culture (PKCm) in the 
third passage clearly demonstrated the diversity of the population. Seven days after 
seeding 192 cells per 10 cm dish, clear colonies had formed and showed the 
following characteristics (summarized in figure 5):  
i) cell morphology:       -     fibroblast-like (A, B, D, F) 
- round-shape (C)   
- epithelial-like, endothelial-like (E) 
ii) cell clone formation:  -     clearly defined (C, E)  
- frayed colonies (B, D, F) 
iii) cell distance:       -     very close (A, C) 
- small (E) 
- huge (B, D, F) 
 
In summary, various different cell morphologies were detected. Presumably, the 
various detected porcine kidney cell types consisted of different types of fibroblasts, 
epithelial and endothelial cells. 
In addition to different morphologies, variable growth rates of several cell clones 
were observed. The growth rates varied between very slow (B, D and F) to quick (A, 
C). The colonies which grew very slowly often stopped growth after a few days. On 
the other hand, in various gene targeting experiments it was observed that very fast 
 A  B 
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growing and strong fibroblast-like cell types, which were sometimes grown in swirls 
showed an acceptable proliferation rate even after splitting and freezing.  
 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4:  Detection of different colony morphologies of PKCm at P3 
Single cell colonies were generated and analyzed of PKC culture. After seven days, various cell 
morphologies were detected. bar = 100 µm 
 
In addition of easy handling during isolation as well as capable detachment and 
growing of the primary cells on culture plates, an important role for further 
applications plays the behavior and changes of PKCs, PFFs and PEFs in culture over 
 A  B 
 C  D 
 E  F 
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a long period. From passage 2 to 13 it is clearly visible that cell populations of all 
three primary cultures became more or less homogeneous containing mostly cells 
with spindle shaped fibroblast-like morphology (Fig. 5).  
 
 P2 P13 
PKCm 
 
 
 
PFF26 
 
 
 
PEF0110 
  
 
Figure 5: Morphological changes after several passages of PKCm, PFF26, PEF0110 cell lines. 
Cell morphology changed from smaller and round-shaped in early passage (P2) to larger and spindle-
shape morphology in later passage (P13).  bar = 100 µm 
 
The diversity of cell types decreased over several passages probably due to the 
culture conditions promoting proliferation of fibroblast-like cells, which overgrew the 
other cell types. In general, a decreasing proliferation rate could be observed over 
time, since splitting intervals increased while splitting ration decreased. Furthermore, 
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in higher passages could be observed that cells increasing their volume in all 
populations. These observations are typical signs of senescence, which were 
described in various publications (Hayflick 1965; Oshimura and Barrett 1997). 
 
4.1.1.2 Growth potential 
 
For detection of growth potential, population doubling time was determined of 
PKCm, PFF26 and PEF0110 cell cultures at P5. For this, 5.5×10
4
 cells were seeded 
onto 12-well plates and cultured for four days. A growth curve was created and 
population doublings and population doubling time were calculated (Fig. 6).  
 
 
Figure 6: Growth curve of primary PKCm, PFF26 and PEF0110 cell lines 
The cell numbers were plotted as Log10 of 10
4
cell/ml against time [h]. Population doublings and 
population doubling time were calculated in the x-marked region during exponential growth phase. 
 
The progression of obtained growth curve reflects the typical growth phases of cells. 
The proliferation was delayed after seeding of cells onto culture plates (lag-phase), in 
which the cells recover from trypsinization, attach and reenter the cell cycle. In 
PFF26 and PEF0110 cultures the cell number decreased in the first 12 h, while the 
PKCm culture showed a slight increase of cell number. In the exponential growth 
phase (log-phase) cells were actively dividing with constant doubling times. After a 
defined time, all primary cells stopped their proliferation due to confluent monolayer 
RESULTS 
- 43 - 
 
resulting in contact inhibition (stationary phase - plateau). It followed last phase, the 
amount of cells decreased as a cause of accumulation of toxic metabolites (PKCm 
and 96 h). 
Population doublings and population doubling time were calculated in the midpoint 
of the exponential growth phase that was between 36 and 60 h after seeding (marked 
with an x in fig. 6). The exponential growth phase increased more sharply in PKCm 
than in PFF26, PFF0110. In addition, PKCm and PFF26 cells showed a higher 
growth potential, since they needed about 22.6 h and 23.4 h for one doubling, 
respectively. In contrast, PEF0110 showed the lowest growth potential with 29.7 h for 
one doubling. In conclusion, PKC showed the shortest population doubling time. In 
this 24 h time period (x-marked period in fig.6) PKCm cell culture has doubled 1.1 
times, PFF26 one time and PEF0110 0.8 times. Furthermore, the better growth 
potential of PKCm cell culture was clearly evident over the whole evaluation period 
of 96 h, where PKCs have doubled 3.4 times, PFFs 2.2 times and PEFs 1.9 times. 
From this follows that at the end of the experiment twofold more of PKCs were 
cultured as PFFs and PEFs. Concretely, 5.9×10
5
 PKCs were counted after 4 d 
compared to 2.6×10
5
 cells of PFFs and 2.1×10
5
 cells of PEFs were detected in the 
same time period. The confluence of each culture was 100% and cells were tight 
together. 
 
Growth potential of cells can be influenced amongst other by the usage of 
extracellular matrix (ECM) proteins, since they are regulating a variety of cell 
functions including cell proliferation, differentiation, adhesion and survival.  
To determine optimal growth conditions kidney cells (PKC2109 or PKCm), fetal and 
ear fibroblasts (PFF26 and PEF0110) were cultured at P5 on 96-well plates without 
coating and coated with gelatin or collagen and analyzed via a MTT based 
proliferation assay. A standard curve was generated for each culture to get an 
indication of obtained cell numbers. The cells were seeded 4 h prior treatment, so that 
cells attached but did not start to proliferate. The cells were seeded with different 
concentrations on 96-well plates in duplicates and after 48 h the MTT treatment was 
started. Metabolic active cells cleaved intracellularly the added tetrazolium salt to 
formazan, which correlates directly to metabolic activity of cells. The formazan 
(yellow) became solubilized into a water-insoluble formazan dye (blue). After 
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overnight incubation, the emerged color intensity was measured and the obtained cell 
numbers were calculated (Fig. 7). 
 
 
 
 
 
 
 Without                      Gelatine                   Collagen 
 
Figure 7: MTT-based proliferation assay to determine appropriate coating type of culture plates. 
PKC2109, PKCm, PFF26 and PEF0110 were cultured onto plates without coating as well as plates 
coated with gelatin and collagen, respectively. The proliferation was detected by MTT-based 
proliferation assay. The assessed cell number after 48 h were plotted against seeded cells t = 0. 
 
PKC2109 cells were seeded in following concentrations: 2000, 5000, 7000, 10000, 
13000, 15000 and 18000 cells per well. After seeding of 2000 PKCs, obtained cell 
number of gelatin and collagen coated wells were similar after 48 h. If 7000 cells or a 
higher cell number were seeded per 96-well, around 40000 cells on collagen-coated 
wells were obtained after 48 h. The proliferation of PKC2109 on collagen is twofold 
stronger than on gelatin and without coating. Less clear results were achieved using 
PKCm cell culture (2000, 3000, 4000, 5000, 6000, 8000, 10000 seeded cells per 
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well). The cells grew better on collagen coating plates compared without coating, but 
similar cell number were detected with gelatin and collagen coating, respectively, 
starting the culture with 2000 to 8000 cells per well. Furthermore, the PKCs grew not 
evenly spread on plates coated with gelatin and without coating but rather in stellar 
islands. In addition, PKCs did not get properly confluent compared to similar cell 
numbers which were seeded on collagen coated wells during the time period of 48 h. 
In proliferation analysis using PFF26 cell culture the differences were not decisive 
between the two coating types. Though, it could be shown that fetal fibroblasts grew 
better on coated culture plates than without coating.  
The ear fibroblast cell culture PEF0110 displayed only marginal differences between 
gelatin and collagen coating, but a tendency of better growing compared to non-
coated plates. 
PKC2109 and PKCm cell culture became faster confluent and obtained a higher cell 
number per 96-well compared to PFF26. The ear fibroblast cell culture PEF0110 
exhibited lowest cell proliferation capacity on each coating type compared to kidney 
cells and fetal fibroblast cell culture, which is comparable to obtained population 
doubling and population doubling time.  
In conclusion, all cell cultures grew better on coated culture plates, whereas collagen 
proved to be the appropriate coating type. 
 
4.1.1.3 Chromosome number 
 
Besides a good proliferation rate of primary cells over a long period, a stable 
karyotype is crucial, especially in higher passages. 
For determination of a stable karyotype, the metaphase chromosomes of several cell 
cultures (PKC, PFF and PEF) were counted at different passages (Tab. 3). The 
counted chromosomes were distinguished in correct (2n=38) and incorrect 
metaphases, which means an aberrant number of chromosomes. All tested cell 
cultures showed predominantly correct karyotypes (2n=38), whereas kidney cells 
exhibited a tendency of more stable karyotype. 
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Table 3: Chromosome number of PKCm, PKC2109, PFF26 and PEF0110 cell cultures. 
 
Passage 
 
Total analyzed 
Metaphases 
2n = 38 (%) 
 
Incorrect 
PKCm 3 35 28 (80) 7 
PKC2109 71 19 14 (74) 5 
PFF26 
5 
13 
14 
25 
9 (64) 
17 (68) 
5 
8 
PEF0110 13 28 21 (75) 7 
 
Chromosomes of metaphases were counted in different passages of various cell cultures. Karyotype 
were distinguished in correct (2n = 38) and incorrect, which means more or less chromosomes. 
 
Beside the good growth potential, kidney cells were capable to be passaged up to P71, 
whereas PEFs and PFFs already showed signs of senescence and can hardly passaged 
longer than 15-20 times. Surprisingly, in P71 PKC2109 cell culture 74% on the 
metaphases showed a correct number of chromosomes, which is similar to PEF0110 
cell culture in P13.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Metaphase of PKC2109 
The correct number of chromosomes (2n=38) of PKC2109 at P71. The cells were treated with 
colcemid. bar = 10 µm 
 
The karyotype analysis shows that primary kidney cell cultures have not only the 
potential to grow much longer than “conventional” fibroblasts, but also show a stable 
karyotype after a long culture period including several cell divisions. 
 
 
4.1.1.4 Somatic cell nuclear transfer – in vitro development competence of cloned 
embryos 
 
 
A further characterization step to define an appropriate cell culture, which is capable 
for generation of transgenic animals, is the determination of the in vitro development 
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competence of cloned embryos. PKCm, PFF26, PEF0110 were cultured and treated 
with serum starvation medium for 48 h. Subsequently, cells were detached and cell 
pellets were given for SCNT (see 3.2.1.11). The cells were used in three independent 
experiments for SCNT and Dr. Mayuko Kurome determined the fusion rate between 
enucleated oocytes and donor cell (Tab. 4) and counted the number of reconstructed 
cultured embryos, which means successfully fused oocytes, embryos developed to 
2-4 cell stage and blastocyst stage. Further, the quality of blastocysts was classified as 
+++ = hatched blastocysts (very good quality), ++ = blastocysts (normal quality) and 
+ = poor blastocysts (poor quality) cultured in vitro after seven days. Subsequently, 
Dr. Mayuko Kurome stained the blastocysts with orcein and introduced me in 
counting the cell nuclei of blastocyst derived from various cell types (Fig. 9). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: In vitro cultivated blastocysts seven days after SCNT using PKCm as donor cells 
A = blastocyst, B = hatched blastocyst. bar = 50 µm 
 
A high fusion rate of 94.4% was obtained using PKCm. Furthermore, 81 
reconstructed embryos could be cultured of which 57 embryos achieved 2-4 cell stage 
(70.4%) and 17 embryos (21%) developed to blastocyst stage. These results were 
significant better compared to PEF0110, where a fusion rate of 82.4% was obtained 
and only three embryos out of 70 reconstructed cultured embryos (4.3%) developed 
to blastocyst stage. Using PFF26 a higher fusion rate of 86% was obtained compared 
to PEF0110, but lower rate of embryos developed to blastocyst stage than with 
PKCm as donor cells.  
Although percentage of embryos developed to blastocysts were significantly 
different, the quality and development into hatched-blastocyst was acceptable using 
 A  B 
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all cell types. Using PKCm and PFF26 as donor cells for SCNT, day seven 
blastocysts contained a higher number of nuclei (43.5-56.1) compared to PEF0110 
donor cells, which is sign for better blastocyst quality (reviewed in Kikuchi 2004; 
Zhu et al. 2004).  
 
Table 4: Overview of in vitro development competences of cloned embryos using PKCm, PFF26 
and PEF0110 cell cultures as donor cells. 
Donor 
cells 
Fusion 
Rate (%) 
No. (%) of 
reconstructed 
embryos 
cultured 
No. (%) of reconstructed 
embryos developed to 
  2-4 cell           Blastocyst 
   stage                  stage 
Quality of 
blastocysts 
No. of cells in 
blastocysts 
[mean+/-SEM] 
PKCm 
85/90 
(94.4)
a
 
81 
(90) 
57  
(70.4) 
17 (21.0)
a
 
+++: 10 
++: 16 
  +: 11 
43.5+/-4.2 
PFF26 
74/86 
(86.0) 
73 
(84.9) 
46  
(63.0) 
7 
(9.6) 
   +++: 15 
   ++: 12 
56.1+/-9.5 
PEF0110 
70/85 
(82.4)
b
 
70 
(82.4) 
48 
(68.6) 
3  
(4.3)
b
 
   +++: 12 
     ++: 11 
23.5+/-7.5 
 
SCNT was performed by transferring nuclei of different cell cultures (PKCm, PFF26 and PEF0110). 
Embryos were cultivated in vitro for seven days up to blastocyst stage. Quality of blastocysts: 
+++ = hatched blastocysts, ++ = blastocysts, + = poor blastocysts. Values with different superscript 
were significantly different (P<0.05), SEM = standard deviation. 
 
4.1.2 Transfection of porcine kidney cells - comparison of different methods 
 
For transfection of primary mammalian cells many commercial kits and reagents are 
available. Since there was no report in the literature about transfection of primary 
PKCs, four different transfection methods, which were used successfully for 
transfection of fibroblasts, were tested. The aim was to find a method resulting in 
good (>50%) transfection efficiency, viable cells of good quality, but causing low 
cytotoxicity after transfection. For this chemical (lipofection, nanofection) and 
physical (electroporation and nucleofection) transfection methods were compared.  
To determine the transfection efficiency, either the commercial vector pmaxGFP
TM
 or 
endotoxin-free purified pmaxGFP
TM
 plasmid were used. Transfection efficiency was 
calculated 24 h post transfection on fixed cells using an epifluorescence microscope 
as follows: 
                                         
                                       
     
During lipofection and nanofection, some experiments were analyzes after 48 h. The 
cell quality including cell morphology was assessed using a grading system ranging 
from 1-5. Fluorescence intensity and number of dead cells were valued by a score 
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system: lowest (-) up to highest (+++) intensity or cell number. Dead cells were those 
swimming in the medium. 
 
4.1.2.1 Chemical transfection by nanofection and lipofection 
 
To determine optimal lipofection conditions 3.2×10
4
 cells (PKC2109) were seeded 
per 24-well. Then, different DNA concentrations (0.25-0.75 µg) and lipid to DNA 
ratios (1:1 – 4:1) were tested as well as varying amounts of Plus reagent (0.25-0.75µl) 
(Tab.5). 
The transfection efficiency results showed a wide range from 0.5 to 54% depending 
on the amount of DNA and plus reagent as well as the lipid to DNA ratio. A low 
amount of DNA (0.25 µg) and Plus reagent (0.25 µl) and low ratio of lipid to DNA 
resulted in good cell quality, which is comparable to the control (rating: 1 to 2) 
without vacuoles, no dead cells and a confluence between 70-100%. Certainly, in 
these experiments transfection efficiency was very low (<4%) and marginal 
fluorescence intensity (score: +) was detectable. A higher ratio of lipid to DNA (4:1) 
resulted in a higher transfection efficiency (26%) and fluorescence intensity 
(score: ++), but also in poor cell quality with stressed and enlarged cells containing 
many vacuoles and lipids. Hence, in following experiments such high ratios were not 
applied. The application of higher amount of DNA resulted in higher fluorescence 
intensity (score: ++), but led also to stressed and enlarged cells (rating: 3 to 5) which 
contained vacuoles and lipids. To determine if lipid drops and vacuoles appeared only 
directly after transfection, particular transfection approaches were analyzed after 48 h 
or splitted 1:3 after 24 h and analyzed 24 h later, respectively. Similar transfection 
efficiency and fluorescence intensity compared to analysis after 24 h could be 
observed by analysis of cells after 48 h. On the other hand, less vacuoles and lipids 
were detected, though cells appeared stressed and enlarged. In addition, more dead 
cells were observed, although toxic lipid vesicles were washed away with PBS after 
24 h and medium was changed. In the other approach, in which cells were splitted, 
similar results could be observed, beside a lot of cells died after passaging. 
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Table 5: Lipofection results 
DNA 
amount [µg] 
Plus 
reagent [µl] 
Ratio 
lipid to 
DNA 
Quality 
Confl. 
[%] 
Dead 
cells 
Fluor. 
intensity 
Transfection 
efficiency 
[%] 
0.25 0.25 
1:1 
2:1 
  2,5:1 
3:1 
4:1 
1 
2 
2 
2 
4 
100 
80-90 
80-90 
70-80 
80-90 
- 
- 
- 
- 
- 
+ 
+ 
+ 
+ 
++ 
0.6 
0.5 
3.1 
3.8 
26 
0.5 0.5 
1:1 
2:1 
  2,5:1 
2,5:1* 
2,5:1* 
2,5:1
a)
 
2,5:1
b)
 
3:1 
  3:1* 
  3:1* 
  3:1
a)
 
  3:1
b)
 
2 
4 
3 
5 
4 
3 
3 
4 
4 
5 
3 
3 
80-90 
70 
70 
50-60 
70-80 
40 
<20 
60 
60-70 
40-50 
40 
<20 
- 
+ 
+ 
+ 
+ 
++ 
+ 
++ 
+ 
++ 
++ 
+ 
+ 
+ 
++ 
++ 
++ 
++ 
++ 
++ 
++ 
++ 
++ 
++ 
2.6 
26 
50 
43 
38 
   30
 a)
 
   18
 b)
 
38 
44 
52 
  43
 a)
 
  24
 b)
 
0.5 1 
  2,5:1 
2,5:1* 
2,5:1* 
2,5:1
a) 
2,5:1
b)
 
 3:1 
  3:1* 
  3:1
a)
 
  3:1
b)
 
4 
4 
4 
3 
3 
4 
3 
4 
3 
60 
70 
60 
50 
<20 
40-50 
70 
50 
<20 
+ 
++ 
+ 
++ 
+ 
++ 
+ 
++ 
+ 
++ 
++ 
++ 
++ 
++ 
++ 
++ 
++ 
++ 
24 
50 
24 
  24
 a)
 
  16
 b)
 
45 
53 
  54
 a)
 
  17
 b)
 
0.75 0.75 
1:1 
2:1 
  2,5:1 
3:1 
4 
5 
5 
5 
80-90 
70-80 
60-70 
60 
- 
+ 
+ 
+ 
++ 
++ 
++ 
++ 
28 
37 
28 
21 
Control        
0 0.5   2.5:1 1-2 70-80 - - - 
 
Analysis of lipofection approaches after 24 h. 
a) 
Analysis after 48 h 
b) 
Cells were splitted 1:3 after 24 h, 
analysis was performed after additional 24 h, * repeat the previous experiment at a different time point. 
Scale for the assessment of cell quality: 1-excellent to good; 2-no vacuoles and lipids detectable, cells 
are bit stressed (stretched); 3-partially vacuoles and lipids, stretched cells; 4-many vacuoles and lipids, 
stressed cells, partially enlarged cells; 5-a lot of large vacuoles and lipids, altered morphology, stressed 
and enlarged cells; Confl.= Confluence after transfection, Fluor. = Fluorescence. 
 
Best results were obtained using 0.5 µg DNA, 0.5 to 1 µl Plus reagent and a lipid to 
DNA ratio of 2.5:1 or 3:1. Thereby, transfection efficiency alternated between 
38 to 54% and acceptable fluorescence intensity (score: ++) and number of dead cells 
(score: + to ++) were observed. However, there was no improvement of transfection 
efficiency, fluorescence intensity as well as cell quality by increasing the volume of 
Plus reagent. The detected confluence correlated to the amount of dead cells. 
 
In order to optimize the transfection efficiency of nanofection, 3.2×10
4
 cells 
(PKC2109) were seeded per 24-well and DNA concentration (0.5-1.5 µg) as well as 
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nanofectin amounts (1.2-4 µl) had to be set up (Tab.6). The transfection efficiency 
using nanofectin ranged from 2 to 25%, therefore being less efficient than lipofection. 
Independently of nanofectin concentration, low DNA amount resulted in excellent to 
good cell quality, which is comparable to the control (rating: 1), low transfection 
efficiencies (10-16%), fluorescence intensity (score: +) as well as dead cell number 
(score: - to +). Stressed cells (rating: 3) containing partially vacuoles and lipids were 
only detected after using very high DNA (1-1.5 µg) and nanofectin amount (2-4 µl). 
Certainly, fluorescence intensity was lower (score: + to ++) compared to lipofection 
using same (0.5 µg) amount of DNA.  
 
Table 6: Nanofection results 
DNA 
amount [µg] 
Nanofectin 
[µl] 
Quality 
Confluence 
[%] 
Dead cells 
Fluor. 
intensity 
Transfection 
efficiency [%] 
0.5 
1.2 
2 
3.2 
4 
1 
1 
1 
1 
80 
80 
80 
80 
- 
-  
+ 
+ 
+ 
+ 
+ 
+ 
10 
16 
16 
15 
1 
1.2 
  1.2* 
  1.2
a)
 
   1.2
b)
 
 2 
   2* 
   2
a)
 
   2
b)
 
3.2 
  3.2* 
  3.2
a)
 
  3.2
b)
 
4 
2 
2 
2 
2 
2 
3 
2 
2 
2 
3 
2 
2 
3 
80-100 
70 
80 
40 
80-100 
70 
80 
40 
80-100 
70 
80 
40 
50-60 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
++ 
+ 
++ 
+ 
+ 
23 
25 
   13
 a)
 
     4
 b)
 
17 
17 
    7
 a)
 
    2
 b)
 
21 
21 
   17
 a)
 
     5
 b)
 
20 
1.5 
2 
3.2 
3 
3 
70 
50 
+ 
+ 
+ 
++ 
 7 
11 
Control       
1 
0 
0 
3.2 
1 
1 
80 
80-100 
- 
- 
- 
- 
- 
- 
 
Analysis of nanofection approaches after 24 h. 
a) 
Analysis after 48 h 
b) 
Cells were splitted 1:3 after 24 h, 
analysis was performed after additional 24 h, * repeat of previous experiment at a different time point. 
Scale for the assessment of cell quality: 1-excellent to good; 2-no vacuoles and lipids detectable, cells 
are bit stressed (stretched); 3-partially vacuoles and lipids, stretched cells, Fluor. = Fluorescence 
 
Also with nanofectin transfection, cell quality after cultivation of cells for 48 h and 
splitted cells after 24 h and following cultivation for 24 h was analyzed. In both 
approaches, no vacuoles and lipids were detected compared to analysis after 24 h, but 
cells appeared a bit stretched and stressed. Furthermore, fluorescence efficiencies 
were reduced and fluorescence intensities as well as number of dead cells were 
similar after 48 h. 
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Best transfection efficiencies (20 and 25%) were obtained using 1 µg of DNA and 
1.2 or 3.2 µl of nanofectin. In these approaches, cell quality and estimated number of 
dead cells was good. 
 
Both, lipofection and nanofection showed increased amount of lipid drops and 
vacuoles after transfection with increasing amount of both DNA and transfection 
reagent (lipofectamin or nanofectin).  
 
4.1.2.2 Physical transfection by electroporation and nucleofection 
 
 
For conventional electroporation of cells (PKC2109) using Bio-Rad Gene pulser II, 
different DNA concentrations (1, 5, 10, 20 µg) and cell numbers (0.5×10
6
, 
1×10
6
 cells) were tested. In addition, several other parameters, like resuspension 
buffer (electroporation buffer from Bio-Rad, DMEM and PBS) and voltages (100 V 
or 230 V) were used to obtain the optimal electroporation conditions (Tab. 7).  
 
Table 7: Electroporation results 
Cell 
number 
DNA 
amount 
[µg] 
Buffer 
Pulse 
duration 
[ms] 
Quality 
Confl. 
[%] 
Dead 
cells 
Fluor. 
intensity 
Trans. 
efficiency 
[%] 
0.5×106 
1 
  1* 
5 
  5* 
  5* 
10 
  10* 
EB 
EB 
EB 
EB 
EB 
EB 
EB 
35,2 
29,8 
34 
27,9 
30,3 
31,9 
29,4 
3 
4 
3 
4 
2 
3 
4 
70-80 
60 
60-70 
80 
50-60 
50-60 
50 
+ 
+ 
++ 
++ 
+ 
++ 
+ 
+ 
+ 
+ 
+ 
+ 
++ 
++ 
28 
25 
46 
38 
41 
47 
45 
1×106 
1 
5 
  5* 
  5* 
5 
5 
5 
5 
10 
  10* 
20 
EB 
EB 
EB 
EB 
  EB
1)
 
PBS 
DMEM 
DMEM 
EB 
EB 
EB 
29,1 
27,2 
28,9 
29,2 
48,8 
8,4 
7,7 
7,5 
26,4 
29,7 
28,4 
4 
4 
3 
4 
2 
2 
2 
2 
4 
4 
5 
70-80 
60-70 
60-70 
50-60 
70 
70-80 
90-100 
90-100 
60 
60 
40 
++ 
++ 
++ 
+ 
++ 
++ 
+ 
+ 
++ 
++ 
++ 
+ 
+ 
+ 
++ 
+ 
+ 
+ 
+ 
++ 
++ 
+++ 
24 
22 
30 
46 
15 
9 
5 
7 
30 
57 
54 
Control         
1x10
6
 0 EB 28,2 4 60-80 + - 0,4 
 
Analysis of electroporation approaches after 24 h, 230 V and high capacity of 500 µF; *previous 
experiment was repeated at a different time. 
1)
chilled buffer. Endotoxin-free purified pmaxGFP
TM
 
plasmid was used.  Scale for the assessment of cell quality: 1-excellent-good; 2-cells are ok, but they 
are bit stressed/stretched; 3-stressed cells with vacuoles; 4-stressed cells with very spindle-shaped 
morphology 5-extreme spindle-shaped and stressed cells with vacuoles. Confl. = Confluence, Fluor. = 
Fluorescence, Trans. = Transfection. 
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Initial experiments (5 or 10 µg DNA and 0.5x10
6
 cells) were carried out using 
electroporation buffer from Bio-Rad and 100 V. 24 h after electroporation, low 
number of dead cells (score: +) and acceptable cell quality were achieved with only a 
few stretched cells, but cells showed no GFP fluorescence. Therefore, following 
experiments were accomplished using a higher voltage (230 V).  
In the control experiment, 1×10
6
 cells were transfected without DNA which resulted 
in stressed cells with very spindle-shaped morphology (rating: 4), but less dead cells. 
The application of chilled electroporation buffer as resuspension buffer resulted in a 
transfection efficiency of 15%, reduced fluorescence intensity (score: +), high amount 
of dead cells (score: ++) and cells at good quality (rating: 2). Chilled electroporation 
buffer resulted to the longest pulse duration with 48.8 ms. In contrast, using PBS or 
DMEM as resuspension buffer the pulse duration was the shortest (7.5-8.4 ms) 
compared to other results. In addition, transfection efficiency of only 5-9% was 
achieved with marginal fluorescence intensity (score: +), but cells were detected with 
good quality (rating: 2). Using PBS, the number of dead cells was increased 
(score: ++) in opposite to DMEM as resuspension buffer (score: +).  
In comparison of several resuspension buffers for electroporation, the most 
appropriate one was the electroporation buffer from BIO-RAD. Best transfection 
efficiency with around 40 to 50% was achieved using 0.5×10
6
 cells with 5 or 10 µg 
DNA and 1×10
6
 cells with 10 or 20 µg DNA. Further, fluorescence intensity varied 
from weak to strong (score: + to +++), but many cells died after electroporation and 
surviving cells showed signs of stress including extreme spindle-shape morphology 
and vacuoles.  
Generally, increasing DNA concentration improved fluorescence intensity and 
efficiency, but very high amounts of DNA (20 µg) resulted in very poor cell quality 
(rating: 5) with extreme spindle shaped and stressed cells containing vacuoles. 
Surprisingly, large variations of fluorescence efficiencies could be detected in 
repeated experiments using 1×10
6
 cells. The efficiency ranged from 22% to 46% 
using 5 µg DNA and 30 to 57% with 10 µg DNA.  
In summary, cells transfected with conventional electroporation method exhibited 
acceptable transfection intensity and efficiency, but showed signs of stress including 
spindle-shaped morphology and vacuoles. 
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An advanced electroporation procedure called nucleofection developed by Amaxa 
(Lonza) with a kit especially designed to transfect mammalian fibroblasts including 
an established protocol was applied. Nevertheless, optimization of experimental 
settings is necessary to a limited extent (Tab. 8). For this, in an initial experiment 
0.5x10
6
 cells of PKC2109 were transfected with 2 µg DNA using different preset 
programs (A-24, T-16, U-12, U-23 and V-13) recommended in the manufacturer´s 
protocol.  
 
Table 8: Nucleofection results 
Cell 
Number 
DNA 
amount [µg] 
Program Quality 
Confl. 
[%] 
Dead 
cells 
Fluor. 
intensity 
Transfection 
efficiency [%] 
PKC2109        
0.5×106 
2 
2 
2 
2 
2 
A-24 
T-16 
U-12 
U-23 
V-13 
2 
2 
1 
2 
1 
70-80 
80 
80 
50 
70 
+ 
+ 
+ 
++ 
+ 
+ 
+ 
++ 
+ 
++ 
28 
54 
63 
60 
59 
0.5×106 
1 
5 
10 
20 
U-12 
U-12 
U-12 
U-12 
1 
1 
1 
2 
90 
90 
80 
70-80 
+ 
+ 
+ 
+ 
+ 
++ 
+++ 
++ 
36 
70 
77 
89 
1×106 
5 
10 
20 
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1 
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  64
2) 
65 
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Control        
0.5×106 0 U-12 1 80-90 + - 0 
PKCm         
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2 
2 
2 
U-12 
T-16 
V-13 
1 
1 
2 
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90 
90 
+ 
+ 
+ 
++ 
++ 
++ 
49 
50 
66 
PFF26        
0.5×106 
 
2 
2 
2 
U-12 
T-16 
V-13 
1 
1 
2 
90 
90 
80-90 
+ 
+ 
++ 
+ 
+ 
++ 
53 
50 
77 
PEF0110        
0.5×106 
2 
2 
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U-12 
T-16 
V-13 
1 
1 
2 
90-100 
90 
70 
+ 
+ 
++ 
+ 
+ 
+ 
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34 
 
Analysis of nucleofection approaches after 24 h. Scale for the assessment of cell quality: 1-excellent-
good; 2-cells are ok, but they were bit stressed/stretched; 3-stressed cells with vacuoles; 4-stressed 
cells with very spindle-shaped morphology 5-extreme spindle-shaped and stressed cells with vacuoles. 
Confl. = Confluence; Fluor. = Fluorescence; 
1)
 other DNA batch (1 µg/µl) 
2)
 error message during 
nucleofection. 
 
24 h after transfection, cells looked very good or a bit stretched (rating: 1 to 2). 
Nucleofection with the program A-24 resulted in the lowest transfection efficiency of 
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28% with low fluorescence intensity (score: +) and few dead cells (score: +). Using 
program U-23, the highest rate of dead cells (score: ++) was determined concurrent 
with high transfection efficiency (60%). The best fluorescence intensity was achieved 
with U-12 and V-13 (score: ++) exhibiting a transfection efficiency of 63% and 59%, 
respectively and cells of excellent quality (rating: 1). Due to this results and the fact 
that U-12 resulted in less dead cells (score: +) than V-13 (score: ++), U-12 was used 
for further experiments with various cell numbers and DNA concentrations. Different 
DNA concentrations (1, 5, 10, 20 µg) were tested with 0.5x10
6
 and 1x10
6
 cells, 
respectively. The obtained transfection efficiency ranged from 36% to 89%. In a 
control experiment, using 0.5×10
6
 cells and nucleofector program U-12 without 
DNA, best cell quality (rating: 1) and less amount of dead cells (score: +) was 
obtained. 
The best transfection efficiency (89%) was achieved with 0.5×10
6
 cells and 20 µg 
DNA. Additionally, the fluorescence intensity (score ++) was good, low number of 
dead cells (score +) and good quality of cell morphology was detected (rating: 2). 
Similar effects were also seen with endotoxin-free prepared pmaxGFP.  
In comparison with conventional electroporation, a similar trend is recognizable: high 
DNA-concentration led to an increase of dead cells as well as fluorescence intensity 
and efficiency, respectively. If it is desired to transfer higher amounts of DNA into 
the nucleus, plasmid DNA up to 20 µg could be transfected without tremendous 
decrease in cell quality and vitality. 
Moreover, nucleofection was suitable for transfection of PKCm culture as well as 
fetal and ear fibroblasts. After transfection of 0.5×10
6
 cells with 2 µg DNA using 
different programs (U-12, V-13 and T-16) best transfection efficiency and 
fluorescence intensity results were obtained using program V-13. However, the 
number of dead cells after treatment of PFFs and PEFs with V-13 was higher 
(compared with U-12 and T-16) and cells showed signs of stress. Overall PEFs 
showed the lowest transfection efficiencies (11-34%) compared to PFF (53-77%) and 
PKC (49-66%) in this approach. The nucleofector programs U-12 and T-16 are the 
most suitable for PKCm, PFF26 and PEF0110 transfection regarding to amount of 
dead cells, quality of surviving cells, fluorescence intensity and transfection intensity. 
 
In summary, comparison of different transfection methods using cell cultures 
originating from different somatic tissues indicate that nucleofection is the most 
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suitable transfection technique to generate genetically modified cells. Moreover, the 
nucleofection of PKCs and PFFs with this system is highly efficient and results in 
viably cells of good quality. The settings for efficient transfection of PEF cell cultures 
could be improved in further experiments. In consequence of all obtained results, 
nucleofection program U-12 was applied for the following additive gene transfer and 
gene targeting experiments. 
 
 
 
4.2 Generation of transgenic animals using PKC, PFF and PEF 
cells as donors for SCNT  
 
Over the past four years a large number of transgenic animals were generated by 
SCNT at the Chair for Molecular Animal Breeding and Biotechnology using different 
lines/populations of PKCs, PFFs and PEF as donor cells. The generation of large 
animal models requires a high degree of expertise. 
 
4.2.1 Additive gene transfer, cloning and recloning using different cell 
populations 
 
The method of nucleofection was used to transfect 0.5×10
6
 to 1×10
6 
cells in P2-P4 
with 1-3 µg endotoxin-free purified and linearized plasmids. Dr. Nikolai Klymiuk 
was responsible for vector design and construction as well as endotoxin-free 
preparation of plasmids. After transfection, cells were plated either onto one 35 mm 
or 60 mm petri dish depending on cell number. After 24 to 48 h, selection was started 
with following antibiotic concentrations: PKC: 10 µg/µl blasticidin S, 0.6 or 1.2 
mg/ml G418, 3 µg/ml puromycin; PEF: 4 µg/µl blasticidin S; PFF:  0.4 or 0.6 mg/ml 
G418. Selection proceeded at least one week, medium was changed every other day 
and cells were splitted once in this time. After selection, cells were cryopreserved or 
used directly for SCNT after starvation. Dr. Annegret Wünsch was responsible for 
generation of most transgenic cell lines. 
In the following, data of the last four years were evaluated. In table 9 and 10, various 
SCNT experiments were compared regarding to the used cell source, total number of 
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born and stillborn piglets as well as litter rates, which were calculated as follows: 
                          
                       
    .  
 
SCNT after first round of transfection 
 
For generation of transgenic animals by additive gene transfer, which results in 
random integration of gene constructs, various primary wild-type cell cultures of 
PKCs and PFFs were used (Tab. 9). In a first round eight different gene constructs 
were stable transfected into three different primary PKC cell cultures, (PKCm, 
PKC2109 and PKC9753). After selection, a mixed population of stable transfected 
PKC clones was used for a total of 29 ETs and resulted in twelve litters (41%) with 
45 animals (including seven stillborn).  
Using stable transfected PFFs with twelve different gene constructs 29 ETs were 
conducted and resulted in 17 litters (59%) with 68 animals overall, of which ten 
animals were stillborn. The efficiency of obtained litters was higher using PFFs 
whereas the number of born piglets per litter was nearly comparable.  
For selection procedure of the first transfection round, either blasticidine (BS) or 
G418 resistance were used. In all experiments there were no clear differences 
identified in efficiency of obtained animals between BS and G418 antibiotic 
resistances. 
In conclusion, three different wild-type kidney cell cultures and two wild-type fetal 
fibroblast cell cultures were capable for production of genetically modified pigs. 
 
Table 9: SCNT using stable transfected cell population 
Cell type 
No. of transgene 
cell lines/ 
populations* 
Passage ET 
No. of 
litters (%) 
Total 
piglets/ 
Stillborn 
1st transfection      
PKC1) 8 6-8 29 12 (41) 45/7 
PFF2) 12 6-8 29 17 (59) 68/10 
2nd transfection       
PKC3) 5 6-8 19 10 (53) 38/12 
PEF 1 7 5 01 (20) 1/1 
 
For additive gene transfer PKC and PFF cell lines were transfected with various constructs. To obtain 
double or triple transgenic animals, PKC and PEF cell cultures were used for an additional transfection 
round. *mixed population: after additive gene transfer; cell line: cell isolation from transgene animals. 
1) 
PKC m, PKC2109, PKC9753, 
2)
 PFF14, PFF26, 
3)
 four different cell cultures were used. 
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SCNT after a second round of transfection 
 
Since a mixed population of transfected and selected cell clones was used for SCNT, 
the generated animals had to be analyzed for transgenesis and expression level in 
desired organs. Animals with best transgene expression were used for breeding, 
recloning or an additional transfection with a further gene construct. 
Hence, it is possible to generate multitransgenic animals by serial transfection and 
cloning. For this, different transgenic PKC cell cultures were used as donors for 
additional five different gene constructs. Out of 19 ETs, we obtained ten litters (53%) 
with 38 animals (of those twelve were stillborn).  
PEFs were used in one experiment for a second additive gene transfer but only one 
litter with one stillborn animal was obtained out of five ETs. 
Using transfected cells of a transgenic animal, the number of stillborn animals 
increased, because 31.6% of the animals were stillborn after SCNT. No living animal 
was born using PEF cell culture of a transgenic animal. In opposite, using transfected 
wild-type cell cultures 15.6% (PKCs) and 15.7% (PFFs) of animals were stillborn. 
 
Recloning experiments 
 
Cloned transgenic animals with the appropriate expression levels in the desired 
organs were reproduced by breeding if the animals were still alive or in recloning 
experiments if the animals had to be killed for expression analysis. Isolated and 
propagated cells of best expressing animals were applied directly for SCNT without 
any further genetic modification.  
Using PKC cell cultures obtained from six transgenic animals with partially different 
transgenic backgrounds, 35 ETs resulted in 16 litters (46%) with overall 48 animals 
including eight stillborn animals (Tab. 10). One PFF cell culture was used for three 
ETs resulting in one litter with two stillborn animals. Using PEF cell culture only five 
of 19 ETs (26%) led to ten piglets (including five stillborn).  
 
In summary, recloning of PKC cell culture is satisfying compared to PFF and PEF 
cell cultures. However, the strong variations in cloning efficiency have to be 
considered when using PEF cell cultures. 
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Table 10: Using donor cells for recloning and cloning SCNT experiments 
Cell type 
No. of transgene 
cell lines/  
Passage ET 
No. of 
litters (%) 
Total 
piglets/ 
Stillborn 
Recloning 
PKC 
PFF 
PEF 
 
5 
1 
3 
 
2-7 
2-3 
2-7 
 
35 
3 
19 
 
16 (46) 
11 (33) 
15 (26) 
 
48/8 
2/2 
10/5 
Cloning      
PFF 2 3-4 24 15 (21) 29/3 
PSF 1 5 2 0 0 
 
PKC, PFF and PEF cell cultures were compared regarding to their cloning and recloning usability. Cell 
line: cell isolation from transgene animals. PSF = porcine skin fibroblasts. 
 
Cloning experiments 
 
 
In addition, cell cultures of bred animals established in another laboratory containing 
three different constructs were cloned (Tab. 10). Often, it is not possible to exchange 
animals between collaborating laboratories; nonetheless shipping of cells is possible. 
These cells were utilized for cloning experiments without further modification. 
Embryos generated with PFF cell cultures were transferred to 24 recipients, resulting 
in five litters (21%) and 29 animals (including three stillborn animals). Using porcine 
skin fibroblasts (PSF) no pregnancy was achieved after two ETs. 
In general, the efficiency of cloning experiments was low using PFF and PEF cell 
cultures. However, these cells were not isolated and cultured at the beginning in our 
laboratory and therefore it is difficult to compare these results with the other SCNT 
results. 
 
In conclusion, large differences in efficiency of obtained litters and litter rates could 
be observed between several experiments using different donor cell types and passage 
number as well as additive gene transfer constructs. 
 
4.2.2 Gene targeting 
 
BAC-vectors were used for site-directed mutagenesis which were designed and 
constructed by Dr. Nikolai Klymiuk. Endotoxin-free purification and linearization of 
these vectors were performed by Dr. Nikolai Klymiuk, Katinka Burkhardt as well as 
Katrin Krähe. The BAC-vectors were nucleofected using 0.5×10
6
 or 1×10
6
 PKCs in 
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P2-P4 and 0.25, 0.5 or 0.75×10
6
 cells of PFF26 in P3. Subsequently, cells were 
cultured onto 6 mm or 10 mm petri dishes, respectively in culture medium for 24 to 
48 h. In contrast to additive gene transfer, it is not possible to use a mixed population 
of cell clones for SCNT. To obtain single cell clones, cells were counted and seeded 
onto 96-well plates for selection 24-72 h after nucleofection (Fig. 10). In some 
experiments transfected cells were mixed (1:1 – 1:3) with non-transfected cells. The 
seeded total number of cells varied between 2000-4400 cells per well. Following 
antibiotic concentrations were used: PKC cultures 1.2 mg/ml G418 or 6 µg/ml 
blasticidine S and fetal cell culture 0.6 mg/ml G418 or 9 µg/ml blasticidine S. The 
medium was changed three times per week. After seven days, 96-well plates were 
screened for single cell colonies.  
 
 
 
Figure 10: Generation of single cell clones in a gene targeting experiment. 
Stable transfected single cell clones were generated during gene targeting experiments onto 96-well 
plates. When reaching confluency of 50-80%, cell clones were propagated by splitting 1:2 to obtain 
cells for cryopreservation and DNA extraction and characterization. 
 
 
Cell clones were splitted 1:2 onto new 96-well plates, if they have reached a 
confluence of 50-80%. Again, when reaching 80-100% confluency, cell clones were 
harvested. The cells of one 96-well were centrifuged (330×g for 10 min), supernatant 
was removed and the pellet stored at -80°C for analysis. The cells of the other 96-well 
were cryopreserved (see 3.3.1.3) for SCNT.  
Obviously, cell cultures used for these procedures need a high proliferation capacity 
and a long lifespan. Therefore, generally cells were used with low passage number 
(P1-P3) for a targeting experiment. After transfection, selection and propagation, the 
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stable transfected single cell clones were used as donors for SCNT in P7 to P10. In 
the following, data of the last two years were evaluated. 
Using PFF26 cell culture, it was not possible to generate targeted cells after ten 
different gene targeting experiments using different BAC vectors, 
DNA-concentrations (1-10 µg) as well as cell numbers (0.25 - 0.75×10
6
 cells). In 
concerning of the difficulties using PFF cell cultures for gene targeting experiments, 
the primary PKCs were used for targeting in four different experiments.   
After targeting one allele, the cell clones were used for SCNT after transfection and 
selection. In summary 19 ETs resulted in seven litters (37%) with a total of 28 
animals (including one stillborn) and two terminated pregnancies (at day 58 and 61, 
respectively) containing 17 fetuses. 
Variations in efficiency (38% - 66.7%) of obtained litters after ETs were observed 
also in gene targeting experiments using different BAC-vectors.  
For sequential targeting of the second allele of one locus, isolated primary PKCs from 
heterozygote animals were used. After transfer of embryos to four recipients, two 
litters (50%) with 11 animals (two stillborn) were obtained (Klymiuk et al. 2011a). 
 
In conclusion, PKCs are useful for gene targeting and these cells were more suitable 
than PFFs and PEFs. Further, targeted PKCs cell clones showed an acceptable rate of 
pregnancies and litter size after SCNT. 
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5 DISCUSSION 
 
Genetically engineered pigs offer great benefits in biomedical research as models for 
human diseases and as organ donors for xenotransplantation (reviewed in Aigner et 
al. 2010). SCNT is used often for the generation of transgenic pigs, due to of several 
advantages such as generation of non-chimeric animals that possess the genetic 
background of the donor cells and it is the only method to introduce site-directed 
mutagenesis in domestic animals (Ross et al. 2009). Thereby, donor cells can be 
modified genetically by additive gene transfer and particularly gene targeting. The 
choice of donor cell type, usage of appropriate transfection method and selection are 
crucial for successfully transgenesis and generation of a pig model.  
 
 
5.1 Morphology and proliferation of primary cell cultures 
 
In the last years, various porcine cell types were used as donor cells for SCNT such as 
MSCs (Jin et al. 2007; Kumar et al. 2007), kidney cells (Yin et al. 2002; Hoshino et 
al. 2005), ear fibroblasts (Faast et al. 2006), adipocytes (Tomii et al. 2009) and 
granulosa-derived cells (Polejaeva et al. 2000) and most frequently wild-type and 
transgenic PFFs (Betthauser et al. 2000; Onishi et al. 2000). Until today, genetic 
modified PKCs have not been used for the creation of transgenic pigs.  
 
The isolation of porcine primary kidney cells as well as fetal and ear fibroblasts was 
simple to perform, beneficial and not laborious compared to other common cell 
isolations such as porcine lung epithelial cells (Blickwede and Borlak 2005), bovine 
muscles cells (Green et al. 2007) as well as isolation of porcine MSC derived from 
bone-marrow and following differentiation into osteocytes (Colleoni et al. 2005). 
After isolation, the primary cells have to adapt to an artificial environment, which 
include changes in O2-level, concentration of nutrition and growth factors as well as 
absence of extracellular matrix constituent and surrounding cell types (reviewed in 
Kuilman et al. 2010). Various types of cell morphology were detected in the initial 
kidney cell culture passage 0. Presumably, these cells are different types of fibroblasts 
like cortical and inner medullary fibroblasts (reviewed in Grupp and Muller 1999). In 
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addition, other cell types were verified such as epithelial cells, dendritic cells, 
macrophages and lymphocyte-like cells (reviewed in Kaissling et al. 1996; Yin et al. 
2002). Probably, PFF and PEF cultures consist of different types of fibroblasts and 
other cell types as well, but it was not clearly visible in passage 0 and after single cell 
clone generation. Various cell types were determined after single cell cultivation of 
PKCs. Thereby, very fast growing and marked fibroblast-like cell types were detected 
also after gene targeting experiments followed by single cell clone generation. It was 
shown that these cells were particularly suitable for splitting, cryo preservation and 
SCNT. It would be a possibility to characterize such well growing cell types and 
adjust the isolation process by, for example gradient centrifugation or antibody 
protein affinity and magnetic bead purification to obtain only the desired cells. On the 
other hand, colonies which grew very slowly often stopped growth after a few days. 
In addition, in long-term analysis it was seen that the diversity, especially in PKCs 
decreased after several passages, because cells with less growth potential were lost 
and cells with high proliferation capacity were enriched. Thereby, PKCs showed an 
increased growth potential compared to PFFs and PEFs also in higher passages. The 
focus is on cells that are cultivatable over several passages for additive gene transfer 
and especially gene targeting experiments, and thus are suitable for SCNT. 
Furthermore, it has to be emphasized that the kidney cells (PKC2109) were 
cultivatable for at least 70 passages after isolation offering a great potential for further 
proceedings. PFFs and PEFs are widely used for genetic modification and due to their 
proliferation and reprogramming properties stopped growing around passages 15-20 
in distinct experiments. The reasons for this could be that somatic cells succumb to 
cellular senescence and thus differ from cancer cells (Hayflick 1965). The Hayflick 
limit (Hayflick and Moorhead 1961) describes a phenomenon where human diploid 
cell strains cannot divide indefinitely, but die after a certain number of divisions 
(approximately 60 to 80 cell divisions). The reason for cellular senescence also called 
replicative senescence is the progressively shortening of telomeres (reviewed in 
Kuilman et al. 2010). DNA polymerase fails to completely replicate the lagging 
strand, which is called “end replication problem” and contributes to telomere 
shortening (Olovnikov 1971; Watson 1972). The proliferation is arrested due to 
critical minimal length of telomeres and results in activation of DNA damage 
response proteins and cell cycle proteins (reviewed in Kuilman et al. 2010). PFFs and 
PEFs seem to reach this limit much earlier than PKCs. It was possible to passage the 
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PKC2109 cell culture more than 70 times, which implies a cell division rate over 150 
times and is more as the Hayflick limit would allow. Presumably, the cells changed 
spontaneously to become a permanently growing (immortalized) cell line during 
cultivation to P71, although they exhibited a stable karyotype, density-dependent 
inhibition of proliferation (contact inhibition) as well as similar proliferation capacity 
as in early passages. Moreover, cellular senescence can be caused by reactive oxygen 
species (ROS) as shown on human fibroblasts (Chen and Ames 1994; von Zglinicki 
et al. 1995). PKCs, PFFs as well as PEFs are growing under standard conditions 
(21% O2, 5% CO2) (reviewed in Simon and Keith 2008). Probably, this means 
oxidative stress for the cells and could contribute to stress-mediated telomere damage 
and resulted in telomere shortening (von Zglinicki et al. 2000). As reviewed by 
Yegorov and Zelenin (2003) a reduced oxygen concentration in culture results in an 
increase in cell life, because the telomere shortening rate and the rate of replicative 
aging can be either increased or decreased by a modification of the amount of 
oxidative stress (von Zglinicki et al. 2000; reviewed in Yegorov and Zelenin 2003). 
Presumably, PKCs are less sensitive to oxidative stress in comparison to PFFs and 
PEFs and can be passaged therefore over a longer period. 
A growth curve was created to determine the population doublings and population 
doubling time of PKCs, PFFs and PEFs. In the first 12 h after seeding, a decreasing 
cell number of PFFs and PEFs was observed, in opposite to the PKC population 
which increases minimally. The proliferation was delayed after seeding of cells onto 
culture plates (Lag-Phase), because cells must adapt to the new growth conditions and 
recover from trypsinization process. Trypsin was used to subculture the cells, 
certainly due to the proteolytic activity, cell surface proteins were cleaved, which 
leads to faulty regulation of cell functions (Huang et al. 2010). It seems that this 
adjustment and recovery proceeded faster in PKCs than in PFFs and PEFs.  
Population doubling time was calculated at the midpoint of the exponential growth 
phase between 36 and 60 h after seeding. PKCm and PFF26 cells showed similar 
population doubling times, since they needed about 22.6 h and 23.4 h for one 
doubling, respectively. I assume that PFFs would need longer for one doubling 
regarding to the whole growth progression. However, the curve did not retained 
constant in this interval, probably due to faulty detachment or counting of cells. After 
a defined time, nutrients are depleted and there was no more of space for 
proliferation, cells achieved the stationary phase and stopped their growing.  
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Furthermore, PFFs and PEFs need more time to double their population in 
comparison to PKCs. A total of 5.9×10
5
 PKCs were counted after 4 d, which is more 
than twice the number of PFFs (2.6×10
5
 cells) as well as PEFs (2.1×10
5
 cells). 
Though PKCs were slightly earlier confluent and entered the last phase of the growth 
curve after 4 d. This implies that PKCs could be smaller compared to PFFs and PEFs, 
because more cells were counted during at 100% confluence. This result indicates 
that PKCs grew much better and faster than the other cell types. The diversity of 
various cells in a PKC culture could influence the growth of cell population in a 
positive way.  
 
In summary, PKCs, PFFs and PEFs were very different regarding their morphology 
and growth potential. PKCs showed higher morphological diversity and grew faster 
compared to PFFs and PEFs. Presumably, PKC are more resistant to oxidative stress. 
Moreover, their sensibility to antibiotic concentrations was different (PKC: 10 µg/µl 
BS, 0.6 or 1.2 mg/ml G418; PEF - 4 µg/µl BS; PFF - 0.4 or 0.6 mg/ml G418) as well 
as to trypsin concentrations (PKCs: 0.4% and PFFs/PEFs: 0.1%). 
 
 
5.2 Promoting of  proliferation capacity using various coatings 
 
Various factors are important for a well growing cell population e.g. medium 
composition, growth density, contact of cells to each other, factors produced by the 
cells themselves and furthermore the coating of culture plates.  
The coating of culture plates with adhesions factors such as fibronectin, poly-lysin, 
laminin, gelatin as well as collagen influences the cell growth. Collagen can be 
divided into 29 various subtypes. Of these, collagen type I is a prevalent substrate for 
the culture of, for instance human fibroblasts (Yashiki et al. 2001), porcine fetal 
fibroblasts (Rogers et al. 2008b) and rat epithelial cells (Strom and Michalopoulos 
1982). Gelatin is a denatured collagen and was used in cell attachment and growth of 
porcine and human fibroblasts and endothelial cells (Wissemann and Jacobson 1985). 
The MTT-based proliferation assay was used to detect optimal coating conditions. 
The assay bases on a color reaction to measure the number of viable cells. Therefore, 
it is possible to detect metabolic active cells, but it does not provide evidence about 
proliferation. 
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In the initial experiment, 2000-18000 PKC2109 cells were seeded per 96-well and 
250-50000 cells were seeded for the standard curve corresponding to (Mosmann 
1983). The differences in the achieved cell number between collagen and gelatin 
coating as well as without were marginal after 48 h. The progression of obtained cell 
numbers was similar to the generated growth curve. Since more than 13000 cells were 
seeded per 96-well, cells were in the death phase after 48 h and a decreased number 
of metabolic active cells could be measured, due to the lack of nutrition and space. 
Further, there were problems during measurement of standard curve in the values of 
250 and 500 cells per well. The MTT-proliferation assay was not sensitive enough for 
such small amounts of cells. Presumably, this could be the reason for the high 
difference between collagen and gelatin as well as without coating in comparison to 
PKCm. For this reason, lower number of cells was used in the experiment and the 
standard curve started at 2500 cells per 96-well in the following experiments. 
Moreover, the stated cell numbers are only indicative, because it is difficult to 
determine a correct cell number after 48 h. The reason therefore is the reference to the 
standard curve, which is sensitive to various factors, including counting and dilution 
of cells as well as treatment of MTT after 4 h, which can be freely determined. In 
growth curve analysis it has been shown that in PFFs and PEFs cell cultures the cell 
number was reduced after subcultivation in the first 12 h, in contrast to PKC cultures. 
That implies a variation of seeded cells after 4 h for determination of standard curve, 
but gave evidence about obtained cell numbers after 48 h. 
In summary, the obtained results showed that all investigated cells grew better on 
coated compared to non-coated plates.  
 
 
5.3 Comparison of non-viral gene transfer efficiencies 
 
Numerous methods have been applied to introduce exogenous DNA into porcine 
fibroblasts, including lipid based delivery (Hyun et al. 2003), electroporation 
(Watanabe et al. 2005) and viral delivery (Rogers et al. 2008b). Each of these 
methods has been used successfully to generate transgenic piglets. Comparing the 
transfection methods lipofection, nanofection, conventional electroporation and 
nucleofection for the genetic modification of PKCs, showed that nucleofection 
resulted in best transfection efficiency and cell quality.  
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In lipofection and nanofection experiments the ratio of DNA to lipid is important for 
efficiency and cellular toxicity (Felgner et al. 1987). The adjustment of lipofection 
parameters was difficult, because amount of DNA, Plus-reagent and lipofection 
solution had to be adapted to PKCs. Vacuoles and vesicles were detected with 
increasing amount of DNA concentration and transfection solution and could have 
caused cytotoxic effects, which were also reported in rat skin fibroblasts with high 
amounts of lipofectin (Nishiguchi et al. 1996). I suggest that the vesicles were formed 
of big DNA-lipid conglomerates, and the vacuoles probably originate from cell stress 
during transfection. After splitting, the transfection efficiency was reduced, probably 
due to stressed and damaged cells which disappeared and untransfected cells which 
have a better proliferation capacity in comparison to transfected cells. The use of 
lipofection for transfection of PKCs resulted in a maximum transfection efficiency of 
~40 to 50%, whereas the quality of the cells was not acceptable because of high 
amounts of DNA and lipofection. Results achieved by lipofection are very 
heterogeneous due to combination of numerous parameters which had to be tested 
due to a lack of established protocols for transfection of kidney cells. Cells with good 
quality (rating: 1 to 2) after transfection were obtained after usage of low amount of 
DNA (0.25 µg), but in these experiments the transfection efficiency was very low 
(0.5 to 3.8%). Colosimo et al. (2000) reviewed that transfection efficiency is 
dependent on cell number, growth state and their state of differentiation, because 
those factors influences the total net charge. It has been shown that kidney cell 
population consists of various cell types with different growth potential, which could 
influence the efficiency. Further, the transfection efficiency dependents on cell 
division, high rate of endocytosis as well as presence of serum (Ross and Hui 1999; 
Gresch et al. 2004). Not only small DNA constructs, but also BAC-vectors should be 
transfectable with lipofection technology for site-directed mutagenesis, but 
McLenachan et al. (2007) demonstrated in mouse embryonic stem cells that the 
nuclear delivery was reduced with increasing plasmid size and linear DNA was 
transfected with lower efficiency than circular DNA.  
The transfection efficiency of nanofection was very low (20-25%) in PKC. To my 
knowledge only Orth et al. (2008) published nanofection efficiencies on various 
human and mice cell lines. They determined high transgene expression by 
chemiluminescence in human chondrosarcoma cells, primary cells from human 
fibrous dysplasia as well as murine fibroblasts (NIH 3T3) but also very low 
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transfection efficiency were achieved in human osteosarcoma cells and murine 
skeletal myoblasts. 
 
In comparison of lipofection and nanofection results, no convincing transfection 
efficiencies were achieved in nanofection experiments. Acceptable transfection 
efficiencies (40 to 50%) were obtained in PKC using lipofection. However, the 
liposomes stressed the cells and had cytotoxic effects, but no long-term study was 
done to assess how cells behave over time.   
 
In addition to the tested chemical transfections, cells are also frequently transfected 
by physical methods. Using conventional electroporation we achieved a maximum 
transfection efficiency of 57% in PKCs, but stressed cells as well as high toxicity 
were observed. Similar cell quality was found in the control transfection without 
DNA. The reason for this could be the usage of high voltage to achieve DNA transfer 
into the cells, because with lower voltage (100 V) successfully transfection was not 
possible. Ross et al. (2010) demonstrated in PFF that elevating voltage (100 to 
350 V) increased transfection efficiency, while survival of cells decreased. 
Furthermore, heterogeneous results could be explained by pulse duration of electrical 
impulse which was clearly visible by using different buffers. Increasing pulse 
duration resulted in increased permeabilization of mammalian cells and improved 
transfection efficiency (Wolf et al. 1994), but could not be adjusted using Gene 
Pulser II (Bio-Rad). Moreover, cells were stressed using high amount of DNA 
(20 µg), probably due to cytotoxic effects of DNA (Sumiyama et al. 2010), and 
general cytotoxicity of electroporation method, which reflects the control approach 
without DNA.  
Nucleofection was applied successfully for transfection of various cell types 
including difficult transfectable cells, such as primary neurons (Leclere et al. 2005) 
and leukemia cell (Schakowski et al. 2004). Furthermore, for many human primary 
cells nucleofection was more convenient than other chemical transfection methods 
(Hamm et al. 2002). A transfection efficiency of 40% was achieved in human renal 
epithelial cells using program T-13/T-20 and 3 µg of DNA (Lonza 2012). 
Nucleofection of PKCs resulted in 82-89% transfection efficiency using program 
U-12 and 20 µg of DNA, whereas the quality of cells was marginal reduced and 
amount of dead cells increased exiguous. To evade negative effects of high DNA 
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amounts, 1-5 µg of DNA was nucleofected 0.5-1x10
6
 cells with program U-12 
resulted in transfection efficiencies between 36-70%. Similar results were achieved in 
PFF using 10 µg pmaxGFP and nucleofector program U-23 (Nakayama et al. 2007). 
Maurisse et al. (2010) reported a transfection efficiency of 90% in PFFs using 
nucleofector program U-20 and 2 µg of pmaxGFP plasmid. The nucleofection 
efficiency in PFFs as well as porcine adult dermal fibroblasts were nearly 100% using 
3.5 µg GFP-plasmid and nucleofector programs U-20 and U-23, respectively 
(Skrzyszowska et al. 2008). Nucleofection of PFFs resulted in 50 to 53% transfection 
efficiency using program U-12 and T-16, respectively and 2 µg of DNA. In 
comparison, higher efficiency of 77% was obtained using program V-13, but 
including higher amount of dead and stressed cells. Low transfection efficiencies (11 
to 34%) were obtained using PEFs regardless of the used nucleofection program. In 
general, it is necessary to choose the best conditions to obtain acceptable transfection 
efficiencies but at the same time cells with good quality. Using nucleofection, low 
cytotoxicity and nearly no change in morphology was detected in transfected PKCs, 
PFFs and PEFs. Previous studies using the nucleofection technology confirmed no 
effects on cell properties, such as alteration of cell morphology, response to chemicals 
and pattern of gene expression (Lakshmipathy et al. 2004; Hagemann et al. 2006). 
Furthermore, purification of expression vector influences transfection efficiency 
(reviewed in Colosimo et al. 2000), but there were no differences detectable using 
commercial pmaxGFP
TM
 plasmid and endotoxin-free prepared pmaxGFP
TM
 plasmid. 
The transformed pmaxGFP
TM
 plasmid was purified endotoxin-free, because removal 
of bacterial endotoxins or lipopolysaccharides resulted in increased transfection 
efficiencies in cultured cells lines such as HeLa cells (Weber et al. 1995).  
 
In conclusion, transfection efficiency with 57% was good using electroporation in 
PKC, but cells appeared extremely stressed. The result after comparing various non-
viral transfection methods strongly suggests that nucleofection enables highly 
efficient gene transfer into PKCs as well as PFFs and PEFs. In addition, nucleofection 
has no limitations concerning safety, insert size and immunogenic reactions such as 
viral transduction (Gresch et al. 2004; Hendrie and Russell 2005). 
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5.4 Efficiency of in vitro/in vivo SCNT  
 
5.4.1 Effects of donor cell source on in vitro development of SCNT embryos 
 
PKCs, PFFs and PEFs were used as donor cells for SCNT to analyze in vitro 
development of SCNT embryos by determination of blastocyst rate and quality which 
is ascertain by the mean number of cells of an embryo in blastocyst stage.  
Table 13 compares the usage of several porcine donor cell types for SCNT and in 
vitro analysis. In various publications the blastocyst rate using PFFs and genetically 
modified PFFs varied from 7% (Betthauser et al. 2000) to 31.2% Onishi et al. (2000), 
whereas in our experiments a blastocyst rate of 9.1% was obtained. Using PKCs as 
donor cells the blastocyst rate with 21% was higher in comparison to the report of 
Yin et al. (2002) with 4% blastocyst rate after six days of embryo in vitro culture. 
Faast et al. (2006) described a blastocyst rate of 18% using PEFs as donor cells, 
which is four times higher compared to our results (4.3%). A much higher rate 
(37.2%) was obtained using adult fibroblasts (Colleoni et al. 2005) which belongs to 
the best results next to the application of MSCs as donor cells.  
Using bone-marrow derived MSCs for SCNT experiments, very high blastocyst rates 
between 29.5% (Faast et al. 2006) to 64% (Kumar et al. 2007) were achieved, in 
comparison to MSCs derived from peripheral blood in which a blastocyst rate of 
18.1% was obtained. The high efficiencies could be explained with better 
reprogramming properties which were analyzed by Kumar et al. (2007). They 
reported that MSCs derived from bone-marrow were more similar to in vivo embryos 
compared to fetal fibroblasts, regarding to expression of key embryonic genes like 
OCT4/NANOG as well as genes involved in  DNA methylation (DNMT1/DNMT3a), 
histone deacetylation (HDAC2) and additional gene expression patterns (Kumar et al. 
2007). On the other hand, a major drawback of MSCs is the verification of 
differentiation capacity by adipogenesis, osteogenesis and chondrogenesis as well as 
immunocytochemical analysis after isolation (Bosch et al. 2006; Faast et al. 2006). 
Moreover, the differentiation verification is laborious and causes high costs for 
required media and growth factors. 
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Table 11: Overview about blastocyst rates using various donor types for SCNT in pig  
Cell type Blastocyst rate [%] Reference 
PFF 
7
(1)
 
6
(1) 
11.9 
12.8 
20 
23 
26 
31 
31.2
(1) 
Betthauser et al. (2000) 
Nakayama et al. (2007) 
Nakayama et al. (2007) 
Kurome et al. (2008) 
Zhu et al. (2004) 
Jin et al. (2007) 
Hyun et al. (2003) 
Kumar et al. (2007) 
Onishi et al. (2000) 
PEF 18 Faast et al. (2006) 
PKC 4
* Yin et al. (2002) 
Adult fibroblasts 37.2 Colleoni et al. (2005) 
MSCs – BM 
29.5 
44.7 
47 
64 
Faast et al. (2006) 
Colleoni et al. (2005) 
Jin et al. (2007) 
Kumar et al. (2007) 
MSCs – B 18.1 Faast et al. (2006) 
Osteocytes 33 Colleoni et al. (2005) 
PSOS 27 Zhu et al. (2004) 
Preadipocytes 33.7-39 Tomii et al. (2009) 
pSGP 27.7 Kurome et al. (2008) 
 
The embryos were cultured in vitro for seven days. PFF: porcine fetal fibroblast; PEF: porcine ear 
fibroblast; MSCs: mesenchymal stem cells derived from bone marrow (BM) and peripheral blood (B), 
respectively; PSOS: fetal porcine skin-originated sphere stem cells; pSGP: salivary gland-derived 
progenitor cells; 
1)
genetically modified donor cells; 
*
embryos were cultures in vitro for six days. 
 
Colleoni et al. (2005) achieved a blastocyst rate of 33% using osteocytes as donor 
cells, which were differentiated in vitro from MSCs. In general, the efficiency of 
blastocyst rate  was very high with 27-39% using fetal porcine skin-originated sphere 
stem cells (Zhu et al. 2004), preadipocytes (Tomii et al. 2009) and salivary gland-
derived progenitor cells (Kurome et al. 2008) as donor cells for SCNT. However, 
these cell types are expensive both in isolation and due to the need of growth factors 
as well as unknown transfectability. 
The efficiencies of various donor cell types for SCNT are contradictory. In pig 
Colleoni et al. (2005) demonstrated similar blastocyst rates that were reconstructed 
with MSCs-BM (44.7%) and adult fibroblasts (37.2%), whereas Faast et al. (2006) 
reported much higher percentage of blastocyst cloned from MSCs-BM (29.5%) than 
those derived from adult fibroblasts (18%). Unlike, Sung et al. 2006 described in 
mice that cloning efficiency increased over the differentiation hierarchy, because they 
have reached greatest cloning efficiency using differentiated granulocytes (34.5%) 
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compared to hematopoietic progenitor cells (10.6%) and hematopoietic stem cells 
(4.1%-7.9%). 
In conclusion, it is difficult to compare cloning efficiencies between different 
laboratories, because a plethora of parameters influence the outcome of SCNT 
experiments. Though, in our hands PKCs were more suitable for generation of cloned 
embryos compared to PFFs and PEFs. Only the comparison of in vitro development 
competence of several different PKC, PFF and PEF cell cultures over time would 
give a more precise picture of the suitability of different donor cell types. 
 
Further, the amount of cells in a blastocyst stage embryo is a possibility to detect the 
quality of in vitro cultivated embryos (Zhu et al. 2004). 200-300 cells/blastocyst were 
counted of in vivo developed blastocyst after seven days (Hunter 1974; Papaioannou 
and Ebert 1988). Kikuchi (2004) reviewed that the mean cell number per blastocyst 
was significant different between in vitro maturation (IVM) and in vitro fertilization 
(IVF) oocytes (74.4 cells per blastocyst) compared to in vitro cultivated embryos after 
six days (38.4 cells per blastocyst). Further, in vitro cultivated embryos did not show 
hatching or hatched blastocysts compared to IVM/IVF blastocysts which developed 
also to hatching blastocysts (134 cells per blastocyst) and hatched blastocyst (215 
cells per blastocyst), equal to that of in vivo matured oocytes (reviewed in Kikuchi 
2004).  
Using PKCm and PFF26 as donor cells for SCNT, a mean cell number between 43.5 
and 56.1 cells per blastocyst was obtained. This cell number is significantly smaller 
compared to in vivo developed blastocyst, but similar to results obtained by other 
laboratories after SCNT using PFF - 53.5 cells per blastocyst (Kurome et al. 2008) 
and 66 cells per blastocyst (Betthauser et al. 2000) after seven days of in vitro 
cultivation. Using PEF0110 as donor cells, the obtained cell number of 23.5 cells per 
blastocyst was very low. The lower amount of cells in blastocyst stage is probably 
due to higher amount of dead cells during development. Presumably, at least one 
arrested and/or dead blastomere of the first four divisions could be responsible for the 
variations of cell number in the blastocyst stage (Leidenfrost et al. 2011). 
 
Taken together, the quality of blastocysts was better using PKCs and PFFs as donor 
cells compared to PEFs. Certainly, the detection of blastocyst cell number as well as 
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blastocyst rate allows no conclusion about the development competence in vivo after 
embryo transfer. 
5.4.2 An overview of cloned transgenic piglets originating from different donor 
cells 
 
In the last years the Chair for Molecular Animal Breeding and Biotechnology was 
able to generate different transgenic pigs using several types of porcine primary cells 
(PKCs, PFFs, and PEFs) transfected with the nucleofector technology.  
Transfection for additive gene transfer or homologous recombination has been done 
with conventional DNA plasmids that were linearized to remove the backbone which 
was important for propagation in bacteria. In BAC vectors the risk to achieve 
undesirable DNA molecules generated by random linearization within the BAC 
construct prior to the integration is reduced (Giraldo and Montoliu 2001). 
 
In additive gene transfer experiments, litter rates between 41% and 50% were 
achieved using transgenic PKCs and PFFs, respectively, after the first transfection as 
nuclear donor cells. In opposite, Hyun et al. (2003) achieved litter rates between 6.7% 
and 7.7% using untransfected and genetically modified PFFs for SCNT. The cells of 
several cloned transgenic animals were used for a second transfection. Here, the litter 
rates were highly different between PKC (52.6%) and PEF (20%) as donor cells, 
taking into account that only one transfected PEF line was used for SCNT and ET, 
whereas five different PKC populations were used. As expected, the obtained 
efficiency after first and second transfection of PKCs as donor cells was similar. In 
recloning experiments, a similar trend was observed in obtained litter rates using 
PKCs (45.2%), PFFs (33.3%) and PEFs (26.7%) as donor cells, which is comparable 
to the in vitro development competence of embryos using several donor cells. In 
addition, also a low efficiency was obtained by cloning of untransfected PFFs with 
21%, whereas no litter was achieved after two ETs using PSF. Lai and Prather (2003) 
got similar cloning success rates between 20-30% using untransfected PFFs. 
Certainly, there were differences in achieved litter rates using transfected (50%), 
recloned (33.3%) and cloned PFFs (21%). This could belong to different stages of 
development and quality of fetuses. In recloning and cloning experiments, cells of 
animals were used which were already generated by SCNT.  
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Classical HR is a widely used method for site-directed modifications in the 
mammalian genome, certainly, the principal limitation of this classical strategy is the 
low targeting efficiency (reviewed in Vasquez et al. 2001). In mice HR in somatic 
cells is less efficient than in ES cells (Arbones et al. 1994; reviewed in Wang and 
Zhou 2003). Due to the fact, that no true ES cells are available in pigs, gene targeting 
of somatic cells results in generation of a high number of cell clones and is laborious 
and costly.  
Rogers et al. (2008b) verified that homologous recombination depends on donor cells. 
They targeted fibroblasts from several fetuses obtained from the same uterus at the 
same time. After targeting which was done by the same people and with same 
reagents, they achieved targeting frequencies between 0.07 to 10.93% (Rogers et al. 
2008b). Using PFFs, we were not able to knock-out a gene on cell culture level, 
probably, due to their reduced growth potential, resulting in low number of cell 
clones after transfection and selection. On the other side, four different loci could be 
targeted using PKCs. SCNT with these successful targeted PKC cell clones resulted 
in cloning efficiencies from 37-50%.  
 
Overall, these data prove that primary PKC as well as PFFs are highly sufficient for 
generation of genetically modified pigs by additive gene transfer. PEFs as donor cells 
were unsuitable for SCNT, because of low efficiency of obtained litter rates. Only 
with PKCs site-directed mutagenesis experiments were successfully. 
 
 
5.5 Outlook 
 
During this thesis, several donor cell sources were characterized and compared for 
generation of transgenic pigs using SCNT. This is a very important point, but merely 
one way to increase the efficiency of generating transgenic piglets. In future projects, 
the focus could be on manipulation of the reprogramming processes of epigenetic 
modifications, because this is a crucial part for dedifferentiation of donor nuclei 
during SCNT. It is presumed that the low cloning efficiency is largely attributable to 
the incomplete and faulty reprogramming of epigenetic modifications (Bourc'his et al. 
2001; Xue et al. 2002; Enright et al. 2003). There are several ways to influence 
epigenetic modifications, for instance the chemical treatment of donor cells, oocytes 
as well as embryos for more efficient epigenetic reprogramming. In pig several 
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studies showed higher blastocyst rate after treatment with histone deacetylase 
inhibitor Trichostatin A of in vitro cultivated porcine embryos and in SCNT embryos 
using PFFs as donor cells (Jeseta et al. 2008; Zhao et al. 2009; Himaki et al. 2010). 
Moreover, Kong et al. (2011) demonstrated the reactivation of silenced transgene 
after treatment with DNA methyltransferase inhibitor 5-Aza-2´-deoxycytidine and/or 
with Trichostatin A in PFFs. 
Another possibility would be the improvement of the selection system for 
side-directed mutagenesis. The used BAC-vectors which were applied for site-
directed mutagenesis contain a positive selection cassette such as blasticidin or 
geneticin resistance gene. The combination of a positive-negative-selection (PNS) 
strategy could increase the efficiency of obtained targeted clones. Cells are selected 
on both integration of the targeting vector due to positive selection and on the HR 
event as well as the resulting loss of the negative selection cassette. In murine ES 
cells 79% targeting efficiency was achieved with PNS strategy (Mansour et al. 1988) 
and 30% targeting efficiency was obtained in a rat fibroblasts (Hanson and Sedivy 
1995).  
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6 SUMMARY 
 
Genetic modification of primary cells for the generation of 
transgenic pig models using somatic cell nuclear transfer 
 
The generation of transgenic pig models is increasingly being established for selected 
human diseases, particularly because of physiological and anatomical similarities 
with humans. Somatic cell nuclear transfer (SCNT) technique was applied to create 
number of genetically modified pigs. Thereby, the type of employed donor cells plays 
a crucial role and should comply with many criteria including efficient isolation, 
simple culture conditions, high proliferation capacity and genetic stability over long 
time culture as well as good in vitro development competence of cloned embryos, 
high transfection efficiencies in combination with low cytotoxicity. 
The aim of this study was the characterization of porcine kidney cells (PKCs) as 
novel donor cell source for generation of transgenic pigs via SCNT and the 
comparison of these cells with widely used porcine fetal fibroblasts (PFFs) as well as 
porcine ear fibroblasts (PEFs). PKC cultures demonstrated large morphological 
variations of cell types and were capable to be passaged up to P71, whereas PFFs and 
PEFs could hardly passaged longer than 15-20 times. Moreover, kidney cells 
exhibited a higher proliferation rate and a twofold higher blastocyst rate was obtained 
after SCNT and in vitro culture. Therefore, PKC culture was used to established 
optimal transfection protocols using lipofection, nanofection, conventional 
electroporation as well as nucleofection. The cells were transfected with green 
fluorescent protein (GFP) as reporter gene. The highest transfection efficiencies 
(70-89%) were obtained using the nucleofection procedure. Moreover, cells showed 
high fluorescence intensity, low cytotoxicity and a good proliferation, with almost no 
signs of stress. Furthermore, nucleofection resulted in acceptable transfection 
efficiencies in both PFF (77%) and PEF (34%).  
Using PKCs as donor cells for SCNT, as well as PFFs and PEFs, our lab 
accomplished successful the generation of various genetically modified pigs. In 
conclusion, PKC showed better proliferation rate, growth capacity, transfection 
efficiency and blastocyst rate after SCNT compared to PFFs and PEFs. Furthermore 
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primary porcine kidney cells are highly sufficient for production of genetically 
modified pigs by gene targeting and additive gene transfer.   
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7 ZUSAMMENFASSUNG 
 
Genetische Veränderung von primären Zellen zur Erzeugung 
transgener Schweinemodelle durch somatischen Kerntransfer 
 
Die Generierung von transgenen Schweinemodellen gewinnt zunehmend an 
Bedeutung für die Erforschung und Behandlung verschiedener Krankheiten des 
Menschen, vor allem wegen ihrer physiologischen und anatomischen Ähnlichkeiten. 
Die Technik des somatischen Kerntransfers (SCNT) wurde verwendet, um transgene 
Schweine zu erzeugen. Hierbei spielt die Art der verwendeten Spenderzellen eine 
entscheidende Rolle und sollten folgende Kriterien erfüllen: effiziente Isolierung, 
einfache Handhabung während der Kultivierung, stabiler Chromosomensatz auch in 
hoher Passagenzahl, hohe Transfizierbarkeit in Verbindung mit geringer Zytotoxizität 
sowie eine gute Entwicklung der Embryonen in vitro nach dem SCNT. 
In dieser Arbeit werden Nierenzellen aus dem Schwein (PKCs) als neuartige 
Spenderzellen für den Kerntransfer beschrieben, charakterisiert und mit fetalen 
Fibroblasten (PFFs) und Ohrfibroblasten (PEFs) aus dem Schwein, welche breite 
Anwendung für den SCNT finden, verglichen. PKCs zeigten in Kultur große 
zellmorphologische Unterschiede und konnten bis zur Passage 71 kultiviert werden, 
wohin gegen PFFs und PEFs  kaum mehr als 15 bis 20mal passiert werden konnten. 
Zudem zeigten PKCs eine höhere Proliferationsrate und die Entwicklungsrate von 
Blastozysten in vitro war doppelt so hoch nach der Verwendung der Zellen für den 
SCNT als mit PFFs und PEFs. Aus diesem Grund wurden für die PKCs die 
optimalste Transfektionsmethode aus Lipofection, Nanofection, der herkömmlichen 
Elektroporation und Nukleofektion  bestimmt. Dazu wurden die Zellen mit dem grün 
fluoreszierenden Protein (GFP) als Reportergen transfiziert. Unter der Verwendung 
der Nukleofektion wurde die höchste Transfektionseffizienz (70 bis 89%) ermittelt, 
sowie eine hohe Fluoreszenzintensitäten und geringe Zytotoxizität erzielt. Die 
Nukleofektion eignete sich ebenfalls für die Transfektion von PFFs (77%) und PEFs 
(34%) mit denen akzeptable Transfektionseffizienzen erreicht wurden.  
Unserem Labor gelang unter anderem die erfolgreiche Generierung von transgene 
Schweinemodellen unter der Verwendung von PKCs als Donorzellen für den SCNT. 
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Zusammenfassend zeigten die Nierenzellen aus dem Schwein bessere 
Proliferationsraten, Transfektionseffizienzen und bessere Blastozystenentwicklung in 
vitro nach dem SCNT als vergleichende Analysen mit PFFs und PEFs. Darüber 
hinaus wurden die PKCs sehr erfolgreich für additiven Gentransfer und das 
Einbringen gezielter Mutationen verwendet, welches Grundvorrausetzungen für die 
Generierung transgener Schweine sind. 
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